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Carotid Intima-Media Thickness is Superior to other Non-Invasive
Functional and Structural Vascular Assessments in Risk Stratification
of Subjects with Established Cardiovascular Disease
KUI-KAI LAU,1 YAP-HANG CHAN,1 KAI-HANG YIU,1 SIDNEY TAM,2 SHEUNG-WAI LI,3 CHU-PAK LAU,1
HUNG-FAT TSE1
From 1Cardiology Division, Department of Medicine, The University of Hong Kong; 2Department of Clinical
Biochemistry Unit, Queen Mary Hospital; and 3Department of Medicine, Tung Wah Hospital, Hong Kong
LAU ET AL.: Carotid Intima-Media Thickness is Superior to other Non-Invasive Functional and Structural Vascular
Assessments in Risk Stratification of Subjects with Established Cardiovascular Disease. Objective: In patients
with known cardiovascular disease (CVD), risk scores based on traditional risk factors of atherosclerosis do not
apply and alternative methods of risk stratification are needed. We aim to compare the prognostic values of a range
of commonly used non-invasive vascular assessments in a group of patients with known CVD. Incremental values of
surrogate markers used in combination would also be assessed. Methods: We determined the brachial endothelial
function (flow-mediated dilatation (FMD), nitroglycerin-mediated dilatation (NMD)), carotid artery atheroma burden
(carotid mean maximum intima-media thickness (mmIMT) and plaque), ankle-brachial index (ABI) and arterial
stiffness (brachial-ankle pulse wave velocity (baPWV)) in 387 patients with known CVD or equivalent (139 patients
with iscahemic stroke (ISS), 130 patient with coronary artery disease (CAD), 100 patients with diabetes without
CAD or ISS and 19 patients with both CAD and ISS). Patients were followed-up at 25±6 months and presence of a
major adverse cardiovascular event (MACE) was documented. Results: During the follow-up period, a total of 46
MACEs occurred. Carotid mmIMT was significantly greater in patients with MACEs (1.18±0.29 mm versus 1.07±
0.31 mm, P=0.027) but there were no significant differences in FMD, NMD, carotid plaque prevalence, ABI or
baPWV in subjects with or without MACEs. Kaplan-Meier curve analysis revealed a significantly greater number of
adverse events in patients with a mmIMT>1.2 mm (P<0.0001 by log rank test) or baPWV>1445 cm/s (P=0.005).
Univariate analysis with Cox proportional hazards modeling identified mmIMT>1.2 mm, baPWV>1445 cm/s,
ABI≤1.1, NMD≤13.5%, age and oral nitrate use as positive predictors of MACEs (all P<0.1). However, multivariate
analysis revealed that out of all non-invasive vascular assessments, only mmIMT>1.2 mm (Hazards ratio 2.49, 95%
confidence interval 1.15-5.39, P=0.020) was an independent predictor of MACEs. Furthermore, patients with a
combined impairment of mmIMT and baPWV was associated with an increased risk of MACE compared with those
with impairment of either marker alone (P=0.007 by log rank test) but did not provide significant incremental benefit
for MACE prediction compared with mmIMT or baPWV alone (P=0.11 and P=0.053 by comparing 2 receiver operating
characterisitic curves). Conclusions: Amongst a range of non-invasive vascular assessments of atherosclerosis,
carotid IMT provides the best predictive value for MACEs in patients with established CVD or equivalent.
Cardiovascular adverse event, carotid intima-media thickness, risk prediction
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Introduction
Various types of risk assessment scores, such as
the Framingham Risk Score have been used for risk
stratification of subjects without established
cardiovascular diseases (CVD). However, these risk
scores are not applicable for patients with established
CVD. Recently, various types of surrogate markers of
atherosclerosis, including vascular endothelial function,
carotid intima-media thickness (IMT) and plaque
burden, ankle-brachial index (ABI) and arterial stiffness
have been increasingly used for the prediction of
cardiovascular events. Several studies have shown that
these markers correlate with the extent and degree of
atherosclerosis,1-10 and have prognostic values in the
prediction of cardiovascular-related events.11-18 Indeed,
recent clinical guidelines have recommended the use
of these markers for risk stratification of asymptomatic
subjects.19,20 However, the relative clinical values of
these different surrogate markers in patients with
established CVD or equivalent remain unclear.
The purpose of this study was to compare the
prognostic implications of several surrogate markers of
vascular assessment including brachial endothelial
function, carotid atheroma burden, ABI and arterial
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ISS

ISS

stiffness in the prediction of cardiovascular events.
Furthermore, the potential incremental prognostic
values of these surrogate makers used in combination
will be assessed.

Materials and Methods
Subjects
The study population comprised of 387
consecutive patients with a known history of coronary
artery disease (CAD), ischaemic stroke (ISS) or diabetes
mellitus (DM) (CAD equivalent).21 The presence of
CAD was defined by a documented history of an acute
coronary event (myocardial infarction or unstable
angina), previous percutaneous coronary intervention,
coronary artery bypass grafting surgery or positive
myocardial perfusion scan. ISS was defined as a
neurological deficit of sudden onset that persisted for
more than 24 hours, corresponded to a vascular territory
in the absence of primary haemorrhage, was not
explained by other causes (trauma, infection, vasculitis),
and was confirmed by computerised axial tomography
or magnetic resonance imaging of the brain. Patients
with haemorrhagic stroke, suspected cardioembolic
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stroke and stroke due to other causes were excluded.
DM was defined as a serum fasting glucose of ≥7.1
mmol/L or on oral hypoglycaemic agents or insulin
injection therapy. The study was approved by the
institutional review board, and all subjects gave written
informed consent.

Study Design
All patients were prospectively recruited between
July 2005 and June 2006 from our medical outpatient
clinics. Baseline demographic data, cardiovascular risk
factors and cardiovascular medications at the time of
recruitment were documented. Cardiovascular risk
factors, including tobacco smoking, DM,
hypercholesterolaemia, hypertension, body-mass index
and family history of CVD in first-degree relatives
younger than 55 years of age were assessed.
Hypertension was defined as either resting systolic or
diastolic blood pressure ≥140/90 mmHg at two different
t i m e s o r o n a n t i - h y p e r t e n s ive m e d i c a t i o n s .
Hypercholesterolaemia was defined as a fasting total
serum cholesterol level of ≥4.9 mmol/L or on lipidlowering medications. Body-mass index was calculated
as weight in kilograms divided by the square of height
in metres. Smoking status was recorded as either smoker
(past and current) or non-smoker.

Vascular Assessments
Vascular ultrasound examinations for brachial
endothelial function, carotid IMT and presence of
carotid plaque were evaluated through a standard Bmode ultrasound examination with the use of a 7.5 MHz
linear array transducer and a high resolution ultrasound
system (Agilent Sonos 5500, Philips, Andover,
Massachusetts, USA) as described previously. 22,23
Measurements of ABI and arterial stiffness were
performed using a commercially available device based
on oscillometric method (VP-2000, Colin Corporation,
Komaki, Japan).
A single experienced operator, who was blinded
to the identity of the study subjects performed all the
vascular ultrasound examinations. Another experienced
operator, also blinded to the identity of the study
subjects, operated on the VP-2000 and obtained the ABI
and arterial stiffness parameters.
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Brachial Endothelial Function
Patients were studied in the fasting state and
vasoactive medications were withheld for 12 hours
before the scans. Longitudinal brachial artery diameter
was obtained at rest, and then during flow-mediated
dilation (FMD), induced by inflation of a pneumatic
tourniquet placed around the forearm to a pressure of
50 mmHg above systolic blood pressure for 5 minutes.
The cuff was then released and serial imaging of the
brachial artery was recorded for 5 minutes. After another
5 minutes of rest, 400 µg of sublingual nitroglycerin
via a spray was administered. The brachial artery
diameter was measured again, 4 minutes after
administration of nitroglycerin. FMD was defined as
the percentage change in brachial artery diameter
between 1 minute after cuff deflation and that on the
baseline scan. Nitroglycerin-mediated dilatation (NMD)
was defined as the percentage change in brachial artery
diameter 4 minutes after administration of nitroglycerin
and that on the baseline scan. All digital images were
stored on optical diskettes for subsequent off-line
analysis using a computer workstation (EchoPAC, GE
Medical, Wisconsin, USA). The brachial artery diameter
was measured by a single operator and an average value
from three consecutive measurements was calculated.
The intra-observer correlation coefficient for FMD
was 0.90 and the intra-observer correlation coefficient
for NMD was 0.86 (2 repeated measurements in 20
randomly chosen subjects).
Carotid Intima-Media Thickness and Plaque
Carotid IMT was determined by measuring
manually the distance between the lumen-intima and
media-adventia border of the vascular wall using
electronic calipers. Each ultrasonic scan was performed
in the anterior, lateral and posterior projections of the
right and left carotid arteries. Three IMT measurements
were made on the near and far wall of the common
carotid arteries, carotid bifurcation and internal carotid
arteries. The mean maximum IMT (mmIMT) was used
for analysis and was calculated by averaging the values
of maximum IMT measured from 12 pre-selected
segments of the carotid arteries. Presence of carotid
plaque was defined as an endoluminal protrusion of the
arterial lumen of at least 0.5 mm or 50% of the
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surrounding IMT value or demonstrates an IMT
of >1.5 mm.24 The intra-observer correlation coefficient
for mmIMT was 0.97 (2 repeated measurements in 20
randomly chosen subjects).
Ankle-Brachial Index and Arterial Stiffness
Subjects were studied under supine resting
conditions in a quiet and temperature-controlled room
for the measurements of ABI and arterial stiffness.
Pneumatic pressure cuffs with oscillometric pressure
sensors were wrapped tightly around both arms and both
ankles. Electrocardiographic electrodes were attached
onto both wrists and a phonocardiogram was placed at
the left second intercostal space, at the margin of the
sternum. After ensuring that the patients have rested
for 15 minutes, a fully automatic data acquisition would
begin. Pressure waveforms of the brachial and posterior
tibial arteries were recorded. Based on the height of the
patient, the device estimated the path lengths from the
brachial artery to posterior tibial artery. Brachial-ankle
PWV (baPWV) was calculated as the path length
divided by the corresponding time interval (cm/s). The
right and left baPWV were averaged and the resulting
value selected as the representative baPWV.
The pneumatic pressure cuffs over the arms and
ankles enabled simultaneous measurement of systolic
blood pressure of the 4 limbs. The right-and left-sided
ABI were calculated as the ankle systolic blood pressure
divided by the brachial systolic blood pressure measured
from right and left side, respectively. The right and left
ABI were averaged and the resulting value selected as
the representative ABI.
The intra-observer correlation coefficient for ABI
was 0.85 and the intra-observer correlation coefficient
for baPWV was 0.98 (2 repeated measurements in 20
randomly chosen subjects).

Clinical Outcome
All patients were followed-up in our clinic
every 3-4 months. Clinical data of all patients were
retrieved from the medical records and subsequently
during the most recent clinic visit. Major adverse
cardiovascular event (MACE) was defined as death
due to cardiovascular causes, acute coronary
syndrome, heart failure hospitalisation, symptom
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driven revascularisation procedures (carotid
endarterectomy, percutaneous coronary intervention or
coronary artery bypass graft surgery) or ISS.
Cardiovascular death was defined as death due to lethal
cardiac arrhythmias, myocardial infarction, heart failure,
fatal stroke or unexplained sudden death. Myocardial
infarction was defined as the presence of chest pain and/
or elevation of creatine kinase >2 times the upper limit
of normal, with or without new ST-segment elevation
(>0.1 mV) in at least 2 contiguous leads. Unstable
angina was defined as hospitalisation because of angina
pectoris that occurred at rest and that was associated
with ECG changes. ISS was defined as clinical and
radiological evidence of stroke without intracranial
haemorrhage. Heart failure hospitalisation was defined
as hospitalisation because of heart failure as diagnosed
by using the modified Framingham criteria.25,26

Statistical Analysis
Continuous variables were presented as
mean±1 standard deviation. Categorical data were
presented as frequencies and percentages. Statistical
comparisons between groups were performed with
Student's t test for continuous variables and Chisquared test for categorical variables. Correlations
between vascular assessment variables were
evaluated by calculating the Pearson's correlation
coefficient. Receiver operating characteristic (ROC)
curves were constructed and the areas under the curve
(AUC) as well as the cut-off values of the vascular
assessments with optimal sensitivity and specificity
were obtained. The standard error (SE) of the AUC
was quoted. Cumulative event rates were calculated
according to Kaplan-Meier method and log rank test.
Cox regression analysis was used to determine the
clinical predictors of MACE. Variables with P<0.1
in the univariate analysis were entered into a
m u l t ivar i a t e a n a l y s i s m o d e l t o i d e n t i f y t h e
independent predictors for MACE.
All calculations were performed with use of
SPSS 15.0 software with the exception of
construction and comparison of the ROC curves
which were calculated using the MedCalc 8.2.1.0
software. A P value <0.05 was considered to be
statistically significant.
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Results

Relationships between Vascular Assessment
Parameters

Clinical Characteristics
The clinical characteristics of the study
population are summarised in Table 1. Their mean age
was 66.4±10.4 years and 251 were men (65%). Among
them, 139 patients (36%) had ISS, 130 (34%) had CAD,
100 (26%) had DM without CAD or ISS, and 18 (5%)
had both CAD and ISS. Furthermore, 268 (69%) patients
had hypertension, 210 (54%) had DM and 245 (63%)
had hypercholesterolaemia.

As shown in Table 2, there were only weak
correlations among different vascular assessment
parameters. Parameters of endothelial function
including FMD and NMD were negatively correlated
with carotid mmIMT (r=-0.12 and r=-0.21 respectively)
and baPWV (r=-0.14 and r=-0.17 respectively) (all
P<0.05). Carotid mmIMT was negatively correlated
with ABI (r=-0.31) and positively correlated with
baPWV (r=0.20) (all P<0.001).

Table 1. Clinical characteristics of the study population
Characteristic
Age, years
Males, n (%)
Body-mass index, kg/m2
Blood pressure, mmHg
Systolic
Diastolic
Hypertension, n (%)
DM, n (%)
Hypercholesterolaemia, n (%)
Smoking, n (%)
Family history of CVD, n (%)
Biochemistry analysis
Total cholesterol, mmol/L
LDL, mmol/L
HDL, mmol/L
Triglyceride, mmol/L
Blood glucose, mmol/L
Medications
Beta-blocker, n (%)
Calcium channel blocker, n (%)
ACEI/ARB, n (%)
Nitrate, n (%)
Aspirin, n (%)
Statin, n (%)

All
(N=387)

With MACE
(N=46)

Without MACE
(N=341)

P-value

66.4±10.4
251 (65)
25.4±3.6

72.0±7.2
30 (65)
25.8±3.5

65.6±10.6
221 (65)
25.4±3.6

<0.0001
0.92
0.43

138.5±20.4
76.1±10.1
268 (69)
210 (54)
245 (63)
167 (43)
23 (6)

144.0±22.8
77.5±12.2
33 (72)
29 (63)
31 (67)
21 (46)
3 (7)

137.7±20.0
76.0±9.8
235 (69)
181 (53)
214 (63)
146 (43)
20 (6)

0.093
0.46
0.38
0.20
0.14
0.36
0.87

4.62±0.90
2.64±0.77
1.33±0.35
1.43±0.82
6.13±2.04

4.59±1.05
2.57±0.94
1.34±0.32
1.47±0.84
6.71±2.77

4.62±0.89
2.65±0.76
1.32±0.35
1.43±0.82
6.08±1.93

0.86
0.60
0.69
0.79
0.18

130 (34)
117 (30)
190 (49)
98 (25)
229 (59)
214 (55)

20 (43)
15 (33)
25 (54)
20 (43)
25 (54)
28 (61)

110 (32)
102 (30)
165 (48)
78 (23)
204 (60)
186 (55)

0.17
0.94
0.27
0.001
0.32
0.75

Abbreviations: MACE=major adverse cardiovascular event; DM=diabetes mellitus; CVD=cardiovascular disease; LDL=lowdensity lipoprotein; HDL=high-density lipoprotein; ACEI=angiotensin converting enzyme inhibitor; ARB=angiotensin receptor
blocker
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Clinical Outcomes
During a mean follow-up of 25±6 months (range
1 month-30 months), 46 MACE were observed in 46
patients (11.9%), including 6 cardiovascular deaths, 6
acute coronary syndromes (2 unstable angina, 3 nonST elevation myocardial infarctions and 1 ST elevation
myocardial infarction), 7 heart failure hospitalisations,
14 revascularisation procedures (all percutaneous
coronary interventions) and 13 ISS.
As shown in Table 1, patients with MACE were
significantly older (72.0±7.2 years versus 65.6±10.6
years, P<0.0001) and were more likely to be treated
with an oral nitrate (43% versus 23%, P=0.001). There
was nonetheless no significant differences in the two
groups in terms of gender, proportion with hypertension,
hypercholesterolaemia or DM, smoking or family
history of CVD (all P>0.05).
Results from different vascular assessment

parameters are shown in Table 3. Patients with MACE
had significantly greater mmIMT (1.18±0.29 mm versus
1.07±0.31 mm, P=0.027) than those without MACE.
However, there were no significant differences in FMD,
NMD, carotid plaque prevalence, ABI nor baPWV
between patients with or without MACE.
ROC curves were constructed to obtain the
diagnostic values as well as optimal cut-off values of
the different vascular assessment parameters (Table 4).
All these parameters had good negative predictive values
(90-98%) but poor positive predictive values (13-23%).
These cut-off points were then used for subsequent
Kaplan-Meier and Cox regression analysis. KaplanMeier analysis revealed that subjects with a raised
mmIMT>1.2 mm (P<0.0001, Figure 1a) and increased
baPWV>1445 cm/s (P=0.005, Figure 1b) were
associated with the occurrence of MACE during followup. In contrast, FMD>2.1% (P=0.10), impaired

Table 2. Pearson correlation coefficients between vascular assessment parameters

NMD
mmIMT
ABI
baPWV

FMD

NMD

mmIMT

ABI

0.41**
-0.12*
0.10
-0.14*

-0.21*
0.10
-0.17**

-0.31**
0.20**

-0.10

Abbreviations: FMD=flow-mediated dilatation; NMD=nitroglycerin-mediated dilatation; mmIMT=mean maximum intima-media
thickness; ABI=ankle-brachial index; baPWV=brachial-ankle pulse wave velocity
* P<0.05, ** P<0.001

Table 3. Vascular assessment parameters of study population
Vascular assessment parameters
FMD, %
NMD, %
mmIMT, mm
Carotid plaque, n (%)
ABI
baPWV, cm/s

All
(N=387)

With MACE
(N=46)

Without MACE
(N=341)

P-value

2.94±2.47
13.76±6.49
1.09±0.31
239 (62)
1.08±0.10
1771±414

3.25±2.12
12.16±5.29
1.18±0.29
30 (65)
1.06±0.13
1845±410

2.90±2.53
14.00±6.63
1.07±0.31
209 (62)
1.08±0.10
1764±416

0.34
0.053
0.027
0.25
0.18
0.27

Abbreviations: MACE=major adverse cardiovascular event; FMD=flow-mediated dilatation; NMD=nitroglycerin-mediated
dilatation; mmIMT=mean maximum intima-media thickness; ABI=ankle-brachial index; baPWV=brachial-ankle pulse wave
velocity
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NMD≤13.5% (P=0.052), the presence of carotid plaque
(P=0.43) and decreased ABI≤1.1 (P=0.062) were not
associated with the occurrence of MACEs.
Univariate Cox regression analysis calculated
that NMD≤13.5%, mmIMT>1.2 mm, ABI≤1.1,
baPWV>1445 cm/s, age and oral nitrate use were
positive predictors of MACE (Table 5, all P<0.1).

Multivariate Cox regression analysis then revealed that
mmIMT>1.2 mm (Hazards ratio [HR] 2.49, 95%
confidence interval [CI] 1.15-5.39, P=0.020) and oral
nitrate use (HR 2.37, 95% CI 1.14-4.94, P=0.021) were
independent predictors for MACE.
The incremental value of using mmIMT and
baPWV together for prediction of MACE was examined.

Table 4. Diagnostic values of various vascular assessments according to specified cut-off values
Marker

AUC (SE) P-value Cut-off
values

FMD
NMD
mmIMT
Carotid plaque
ABI
baPWV

0.56±0.05
0.58±0.05
0.63±0.05
0.53±0.05
0.56±0.05
0.55±0.05

0.27
>2.1%
0.10
≤13.5%
0.005 >1.2 mm
0.54
0.20
≤1.1
0.32 >1445 cm/s

Sensitivity, %
(95% CI)

Specificity, %
(95% CI)

Positive
predictive
value, %

Negative
predictive
value, %

72.5 (56.1-85.4)
71.8 (55.1-85.0)
46.5 (31.2-62.3)
69.8 (53.9-82.8)
85.7 (71.4-94.5)
97.2 (85.4-99.5)

41.5 (35.9-47.2)
43.8 (38.0-49.6)
78.9 (74.1-83.2)
36.1 (30.9-41.6)
30.2 (25.1-35.7)
21.4 (16.8-26.5)

14.0
14.4
22.5
12.6
14.3
13.1

92.0
92.2
91.8
90.1
93.9
98.4

Abbreviations: AUC=area under curve; SE=standard error; CI=confidence interval; FMD=flow-mediated dilatation;
NMD= nitroglycerin-mediated dilatation; mmIMT=mean maximum intima-media thickness; ABI=ankle-brachial index;
baPWV= brachial-ankle pulse wave velocity

(a)

(b)

Abbreviations: MACE= major adverse cardiovascular event; mmIMT= mean maximum imtima-media thickness; baPWV= brachial-ankle
pulse wave velocity

Figure 1. Kaplan-Meier curves for the development of MACE in patients with (a) mmIMT>1.2 mm or ≤1.2 mm and (b) baPWV>
1445cm/s or ≤1445cm/s
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Table 5. Cox regression analyses for MACE in patients with CVD
Univariable
HR (95% CI)

Multivariable
HR (95% CI)

P-value

P-value

FMD>2.1%

1.74 (0.87-3.50)

0.12

NMD≤13.5%

1.97 (0.98-3.97)

0.058

1.17 (0.54-2.55)

0.69

mmIMT>1.2 mm

2.88 (1.58-5.25)

0.001

2.49 (1.15-5.39)

0.020

Carotid plaque

1.30 (0.68-2.49)

0.43

ABI≤1.1

2.23 (0.94-5.30)

0.069

1.14 (0.43-3.04)

0.79

baPWV>1445 cm/s

10.04 (1.37-73.4)

0.023

6.76 (0.90-50.67)

0.063

Age

1.07 (1.03-1.10)

<0.0001

1.03 (0.99-1.08)

0.16

Male gender

1.09 (0.59-2.00)

0.78

Body-mass index

1.04 (0.96-1.12)

0.39

Hypertension

1.43 (0.68-2.98)

0.35

DM

1.63 (0.88-3.01)

0.12

Smoking

1.28 (0.70-2.34)

0.43

Family history of CVD

1.01 (0.31-3.27)

0.98

Beta-blocker

1.70 (0.91-3.16)

0.10

Calcium channel blocker

1.29 (0.68-2.46)

0.43

ACEI/ARB

1.44 (0.78-2.74)

0.27

Nitrate

1.97 (1.08-3.61)

0.008

2.37 (1.14-4.94)

0.021

Aspirin

0.84 (0.44-1.60)

0.59

Statin

1.15 (0.63-2.08)

0.65

Risk variable

Abbreviations: MACE=major adverse cardiovascular event; CVD=cardiovascular disease; HR=hazards ratio; CI=confidence
interval; FMD=flow-mediated dilatation; NMD=nitroglycerin-mediated dilatation; mmIMT=mean maximum intima-media
thickness; ABI=ankle-brachial index; baPWV=brachial-ankle pulse wave velocity; ACEI=angiotensin converting enzyme inhibitor;
ARB=angiotensin receptor blocker

In Kaplan-Meier analysis, either increased mmIMT or
baPWV was associated with an increase risk of MACE
compared with patients with a normal mmIMT and
baPWV (P=0.045, Figure 2). Furthermore, patients with
both increased mmIMT and baPWV were associated
with a further increase risk of MACE compared with
those with increased either marker alone (P=0.007,
Figure 2). Nevertheless, the combination of mmIMT
and baPWV (AUC=0.67) did not provide significant
incremental benefit for MACE prediction compared
with mmIMT (AUC=0.63, P=0.11) or baPWV
(AUC=0.55, P=0.053) alone.
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Discussion
The results of this study demonstrated that in a
population with established CVD or equivalent,
increased mmIMT or baPWV were associated with
increased risk of MACEs upon follow-up. However,
multivariate analysis revealed that only an increased
mmIMT>1.2 mm was an independent predictor for
MACE and that subjects with mmIMT>1.2 mm were
associated with a 2.5-fold increased risk of developing
MACEs. In contrast, parameters of brachial endothelial
function (including FMD and NMD) and ABI did not
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have significant prognostic values. Although patients
with both increased mmIMT and baPWV had a
significantly greater risk of developing MACEs, the
combined use of both parameters did not significantly
increase the prediction value for adverse clinical
outcome.
Carotid IMT has been shown to be one of the
most promising non-invasive surrogate markers of
predicting clinical outcomes in patients with CVD.
Indeed, both the American Heart Association and the
Society for Heart Attack Prevention and Eradication
have recommended the use of carotid IMT as a
s u r r o g a t e m a r k e r f o r r i s k s t r a t i fi c a t i o n i n
asymptomatic subjects. 19,27 A recent meta-analysis
which included 37,000 individuals also concluded
that carotid IMT was a strong predictor of future
vascular events. 14 The results of the present study
confirmed this finding and demonstrated that carotid
IMT has the best prognostic value among different

Abbreviations: MACE= major adverse cardiovascular event;
mmIMT= mean maximum imtima-media thickness; baPWV=
brachial-ankle pulse wave velocity

Figure 2. Kaplan-Meier curves for the development of
MACE in patients with 1) both mmIMT>1.2 mm and
baPWV>1445 cm/s, 2) either mmIMT>1.2 mm or
baPWV>1445 cm/s and 3) both mmIMT≤1.2 mm and
baPWV≤1445 cm/s.
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vascular surrogate makers in a patient cohort with
established CVD. Whilst previous studies have
identified an increased mmIMT>1 mm as a predictor
for CVD events in the general population, 5 the
optimal cut-off value of mmIMT in the prediction of
MACE identified in the present study was >1.2 mm.
This is likely because of the patient population
included in this study had underlying CVD and thus
their baseline IMT values would be expectedly much
higher than the general population. As a result, a higher
cut-off value of >1.2 mm for carotid mmIMT was
required to identify patients at greatest risk of
developing a recurrent major cardiovascular event.
Previous studies have shown that the presence
of carotid plaque is also a good predictor for CVD.28
Based on the definition of carotid plaque from the
Mannheim Carotid Intima-media Thickness
Consensus,24 we failed to demonstrate the predictive
value of the presence of carotid plaque for MACE in
patients with CVD. A more detailed assessment of
carotid plaque by measuring the plaque area or even
plaque volume may provide a more sensitive and
better assessment of the burden of atherosclerosis,
and thus improve its prognostic value.29,30
Arterial stiffness, as measured by baPWV has
been suggested as a promising marker to predict adverse
events in a high risk population. Previous studies have
shown that increased arterial stiffness was associated
with an increased risk of CAD and stroke. 31-34
Furthermore, increased arterial stiffness has been
identified as an independent predictor of all-cause and
cardiovascular mortality in hypertensive patients.17 It
has been postulated that an increased arterial stiffness
is closely correlated with left ventricular hypertrophy,
arterial wall thickening and atherosclerosis which could
potentially contribute to the higher risk of adverse
clinical outcomes in patients with CVD.35-37 In this study,
patients with higher baPWV had a significantly
increased risk of MACEs. However, multivariate
analysis failed to demonstrate baPWV as an independent
predictor for MACEs in patients with CVD. The use of
ABI, another structural assessment of the peripheral
vascular system, also did not predict the occurrence of
MACEs in this study. Indeed, the use of ABI as a
surrogate marker is rather complicated as both low

October 2008

48

VASCULAR ASSESSMENTS AND RISK STRATIFICATION IN CARDIOVASCULAR DISEASE

(<1.0) or high (>1.4) ABI are associated with the
presence of peripheral vascular disease.38 Therefore,
ABI is a less sensitive marker to predict MACEs in
patients with established CVD as such subjects might
have both low and high ABI values.
Endothelial dysfunction represents an early
phenomenon of atherosclerosis preceding structural
changes and clinical manifestations. 39 In low risk
subjects without established CVD, the presence of
endothelial dysfunction have been shown to predict
the occurrence of adverse clinical events. 23,40
However, assessment of endothelial function
appeared to have limited prognostic value in high risk
subjects and patients with established CVD.20,41,42 The
results of this study supported these findings and
demonstrated that brachial FMD did not predict
MACEs in our patient cohort with established CVD
or DM. In contrast, NMD, a marker which reflects
the ability of vascular smooth muscle relaxation, has
previously been shown to be impaired in subjects with
cardiovascular risk factors as well as in patients with
established CAD.43,44 In this study, patients with an
impaired NMD was associated with an increased risk
of developing MACEs. Nevertheless, impaired NMD
was not an independent predictor for MACE. On the
other hand, the use of oral nitrate was shown to be an
independent predictor for MACE. Although the
reason remains unclear, it is possible that oral nitrate
was more likely prescribed in patients with more
severe CAD or it may be related to the potential
adverse effects attributed to the long-term use of oral
nitrate.45

Conclusions
The results of this study suggested that the
measurement of carotid IMT as a non-invasive structural
marker of atherosclerosis provides the best predictive
value for MACEs in patients with established CVD or
equivalent, and the combined use of vascular surrogate
markers did not further improve their predictive value.
Nevertheless, whether the regression of carotid IMT in
those higher risk patients can reduce the risk of MACEs
remains unclear.
49
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IL1.
HEART FAILURE IN CHINA: PREVALENCE AND CURRENT
TREATMENT
Philip YA Ding
Professor of Cardiology and Critical Care Medicine, National Yang-Ming
University, Taipei Veterans General Hospital, Taipei, Taiwan
Heart failure (HF), a major cause of morbidity and mortality, is reported to
consume 2% to 3% of the total health care costs in industrialized countries.
The age-adjusted mortality for HF patients is four to eight times that of the
general population, comparable to that of cancer diseases in the same age
groups. The predominant causes of HF are hypertension and coronary heart
disease (CHD). Other identified risk factors for HF include left ventricular
(LV) hypertrophy, valvular heart disease, diabetes mellitus, cigarette
smoking, obesity, and dyslipidemia. Population-based studies to date have
shown different results concerning the relative importance of these risk
factors. In the past decade, considerable knowledge has been gained regarding
the pathophysiology of HF in the experimental setting, small clinical samples,
and larger population-based studies. New mechanisms, such as insulin
resistance, inflammation, and oxidative stress, have been investigated.
Epidemiologic studies revealed that these mechanisms are largely established
in the general population.
Based on the 2001 Chinese national survey of cardiovascular diseases and
risk factors study, a total of 15,518 adults were collected from 10 provinces
of China (5 in the North and 5 in the South) with an equal distribution from
urban and rural populations. The prevalence of chronic heart failure (CHF)
was 0.9%, 0.7% and 1.0% for the general population, the males and females,
respectively. Females with CHF were more frequent than males (p<0.05).

CHF prevalence was 0.4%, 1.0%, 1.3% and 1.3% in the 35-44, 45-54, 5564, and 65-74 years of age, respectively. The prevalence rate of CHF
increased substantially with aging. The figure of prevalence of CHF was
1.4% and 0.5% in northern and southern population, respectively; and the
figure was 1.1% and 0.8% in urban and rural population, respectively. The
risk of CHF was higher in northern than in southern China and was higher
in urban than in rural area.
Over the last two decades, major advances have occurred in the treatment of
heart failure patients. Randomized clinical trials showed that ACE-inhibitors,
angiotensin receptor blockers, β-blockers, and aldosterone antagonists as
well as mechanical circulatory support devices can reduce morbidity and
mortality in patients with heart failure. Guidelines have been established to
help physicians in reaching a clinical decision - making this a rapidly
evolving field. In China, most physicians are increasingly encouraged to
apply the most updated treatment guidelines in their practice. However, there
is a considerable proportion of heart failure patients who do not receive
evidence-based treatment. Several factors may explain the reported underutilization of evidence-based treatment such as lack of knowledge and
technical expertise of the physicians, economic restraints, and family wishes
from patients.
In conclusion, among cardiovascular diseases, heart failure is becoming an
important issue of public health in China.

IL4.
HEART FAILURE: A VASCULAR DISEASE?
V Richard
Department of Pharmacology, Rouen University Hospital, Rouen France
Although heart failure (HF) is by definition a disease mostly affecting the
cardiomyocytes, there is also growing evidence that this disease has important
consequences for the vasculature, and especially impacts the vascular
endothelial cells, both at the coronary and peripheral levels.
At the coronary level, HF markedly alters coronary endothelial function and
especially the release of endothelium-derived factors such as nitric oxide (NO).
Given the role of this factor as a regulator of vasodilator tone, but also as an
important inhibitor of platelet aggregation and leukocyte function, it is likely
that such an impaired NO production not only will contribute to increased
vasoconstriction, but also will favour thrombosis and atherosclerosis, thus
increasing the risk of (re)infarction and aggravating HF. In parallel, the
development of HF is associated with a progressive reduction of coronary
arteriolar and capillary density (due at least in part to impaired coronary
angiogenesis). Such reduced vascular density, and the resulting impaired
cardiac perfusion is now recognized as a critical determinant of the aggravation
of HF and of cardiac decompensation.
At the peripheral level, there is growing evidence that HF also profoundly
impairs physiological NO production, notably at the level of small peripheral
arteries. Such impairment is especially important since it will contribute to
peripheral vasoconstriction and will potentiate the effects of the major
vasoconstrictor systems known to be activated in HF (i.e. the renin-angiotensin,
endothelin and sympathetic systems). This results in an increased peripheral
vascular resistance which augments the afterload of the heart, ultimately
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aggravating HF. The impaired peripheral production of NO appears to be the
consequence of interaction between mechanical (e.g. chronic decrease in blood
flow), neurohumoral (e.g. angiotensin) and inflammatory (e.g. reactive oxygen
species and TNFα) influences.
Importantly, endothelial dysfunction in HF can be reduced by various
pharmacological approaches, including 'classic' treatments of HF (e.g.
angiotensin converting enzyme inhibitors such as perindopril) and more recent
treatments (e.g. heart rate lowering agents such as ivabradine). In addition,
recent therapies have emerged and appear promising in the treatment of HFinduced endothelial dysfunction, including modulators of endothelial
phosphorylation pathway (e.g. using tyrosine phosphatase inhibitors), which
may provide new clinical opportunities for the treatment of HF.
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Abstracts for Invited Lectures:
IL6.
ENDOTHELIAL PROTECTIVE EFFECT OF NUCLEOSIDE
UPTAKE INHIBITORS
GPH Leung
Department of Pharmacology, The University of Hong Kong, Hong Kong
SAR, China
Inflammation of endothelium is closely associated with the development of
atherosclerosis. It has been well established that interstitial level of adenosine
is increased during inflammation. Adenosine possesses anti-inflammatory
property so it may serve to protect tissues from injury and potentially slow
down the progression of atherosclerosis. The increase in extracellular
adenosine level at the sites of inflammation is mainly due to the up-regulation
of ecto-5' nucleotidase by phosphoinositide 3-kinase (PI3K)-dependent
pathways. The ecto-5' nucleotidase catalyses the conversion of extracellular
adenosine nucleotides into adenosine.
Patients with diabetes mellitus suffer greater morbidity from atherosclerosis.
Glucose per se does not affect ecto-5' nucleotidase but it increases the
expression levels of equilibrative nucleoside transporters (ENTs) via
mitogen-activating protein kinase (MAPK)-dependent pathways. It is
speculated that the increase in ENTs may reduce the availability of adenosine
in the vicinity of adenosine receptors, thereby attenuating the antiinflammatory effect of adenosine in diabetes.
The anti-inflammatory effect of adenosine can be potentiated
pharmacologically by ENT inhibitors, of which nitrobenzylmercaptopurine
ribonucleoside (NBMPR) and dipyridamole are the representatives. No oral
hypoglycemic agents can inhibit ENTs except troglitazone. Unfortunately,
this thiazolidinedione has been withdrawn from the market. Screening of

anti-hypertensive agents has revealed that ENTs are sensitive to
dihydropyridine-type calcium channel antagonists, particularly nimodipine,
which can inhibit ENTs in nM range. Those calcium channel antagonists
are non-competitive inhibitors of ENTs, probably working through the
reversible interactions with allosteric sites. In vitro study has demonstrated
that nimodipine and nifedipine can reduce the lipopolysaccharide-induced
interleukin-8 release in endothelial cells. This effect is independent of their
inhibitory effects on calcium channels but is more likely to be due to the
blockade of ENTs. Therefore, while treating vascular diseases such as
hypertension and angina pectoris, dihydropyridines may have an additional
beneficial effect in attenuating endothelial inflammation and hence,
ameliorating atherosclerosis and its complications.

IL11.
B E R B E R I N E A S A P OT E N T I A L D RU G F O R T H E
T R E AT M E N T A N D P R E V E N T I O N O F VA S C U L A R
DYSFUNCTION IN OBESITY AND DIABETES
Y Wang,1 Y Huang,2 Karen SL Lam,1 Chi-Wai Lau,2 Paul M Vanhoutte,3
A Xu1,3
1
Department of Medicine, The University of Hong Kong; 2Department of
Physiology, The Chinese University of Hong Kong; 3 Department of
Pharmacology, The University of Hong Kong, Hong Kong SAR, China
Introduction: Vascular disorder is a common soil for many deadly diseases
and is one of the most common complications observed in Type 2 diabetes.
Endothelial dysfunction, characterized by impaired vasodilation, is a key event
that links obesity, diabetes, hypertension and vascular diseases. The AMPactivated protein kinase (AMPK) plays a key role in endothelial cell, including
protection of cells from apoptosis, inhibition of inflammation and stimulation
of angiogenesis. The objectives of this study are to evaluate the protective
effect of berberine, an alkaloid purified from traditional Chinese medicine,
against hyperglycemia-induced cellular injury, endothelial dysfunction, and
to investigate the potential role of AMPK pathway in this process.
Method: Berberine was tested for its effect on the production of nitric oxide
(NO), activation of eNOS as well as the association of eNOS with heat shock
protein(HSP)90 and AMP-activated protein kinase (AMPK) in human
umbilical vein endothelial cells (HUVEC). The effect of berberine on vascular
reactivity was examined on aortic rings isolated from rats. In addition, berberine
was also evaluated for its actions on inhibiting production of intracellular
ROS, apoptosis and NF-κ B activation under hyperglycemia circumstance.
Results: In cultured endothelial cells and blood vessels, berberine dosedependently enhanced eNOS phosphorylation and promoted the association
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of eNOS with heat shock protein (HSP)90, leading to an increased production
of nitric oxide (NO). Furthermore, berberine attenuated high glucose-induced
generation of reactive oxygen species (ROS), cellular apoptosis, NF-κappaB
activation and expression of adhesion molecules, thus suppressing monocyte
attachment to endothelial cells. In rat aortic rings, berberine elicited
endothelium-dependent vasodilatations and alleviated ROS-mediated
endothelial dysfunction. These beneficial effects of berberine on the
endothelium were abolished by either pharmacological inhibition of AMPactivated protein kinase, or adenovirus-mediated overexpression of a dominant
negative version of AMPK.
Conclusions: The present results demonstrate that berberine protects against
endothelial injury and enhances NO-dependent vasodilatation through
activation of the AMPK/eNOS signaling cascade. Berberine or its derivatives
may be useful for the treatment and/or prevention of endothelial dysfunction
associated with diabetes.
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A COMPOUND FROM CHINESE MEDICINAL HERB
P R OV I D E S A P O T E N T I A L C U R E F O R AT R I A L
FIBRILLATION
GR Li
Departments of Medicine and Physiology, The University of Hong Kong,
Hong Kong SAR, China
Atrial fibrillation (AF) is the most common form of cardiac dysrhythmia. It
increases the risk of death, congestive heart failure, and embolic phenomena
including stroke. AF is believed to be a lifetime risk in an aging population.
Antiarrhythmic drug therapy remains the principal approach for suppressing
AF and its recurrence. Class III anti-arrhythmic agents are effective in treating
AF, but have major limitations, such as inducing severe ventricular arrhythmia
(i.e. long QT syndrome). A key objective among the current strategies for
suppressing AF is the development of new Class III antiarrhythmic agents
that preferentially affect atrial rather than ventricular electrical parameters.
Pharmaceutical researchers have been focusing on developing selective
inhibitors of the human atrial IKur or hKv1.5 channels, which is present in
atrium, but not in ventricles of the human hearts. However, there is no such
drug commercially available yet. We have been investigating traditional
Chinese medicine to find selective IKur blockers for the treatment of atrial
fibrillation. By collaborating with Shanghai Institute of Materia Medica,
Chinese Academy of Science, we have recently found that the natural flavone
acacetin from the Chinese medicine Xuelianhua selectively inhibited human
atrial ultra-rapid-delayed rectifier K+ current (IKur) and transient outward K+
current (Ito), and prolonged action potential duration in human atrial myocytes.
The compound blocked acetylcholine-activated K+ current; however, it had
no effect on other currents in guinea pig cardiac myocytes. In anesthetized
dogs, acacetin prolonged atrial effective refractory period (ERP) after

J HK Coll Cardiol, Vol 16

intraduodenal administration without QTc prolongation, whereas the clinical
drug sotalol prolonged atrial ERP, and ECG QTc interval. In addition, acacetin
prevented AF induction in anesthetized dogs. Our study demonstrates that
acacetin targets to human atrial repolarization currents and is an atrial selective
agent. It effectively prevents AF induction in anesthetized dogs after
intraduodenal administration, indicating that oral acacetin is a promising atrialselective agent for the treatment of AF. Therefore, the natural compound
acacetin from the traditional Chinese medicinal herb Xuelianhua provides a
potential cure for atrial fibrillation.
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CONTRACTILE RESPONSE TO HYPOXIA IN THE PORCINE
CORONARY ARTERY
CKY Chan, J Mak, RYK Man and PM Vanhoutte
Department of Pharmacology, The University of Hong Kong, Hong Kong
SAR, China
The contractile response to hypoxia has been studied in the lung, and is termed
hypoxic pulmonary vasoconstriction. However this response is also observed
in coronary arteries. The present study investigated the mechanism underlying
this contractile response in isolated porcine coronary arteries. Isometric tension
was measured in rings with or without endothelium. In quiescent preparations,
the contractile response to hypoxia was only observed in rings with
endothelium and was abolished by indomethacin and terutroban, which shows
the involvement of cyclooxygenase products and TP receptor activation,
respectively, in this phenomenon. In contracted preparations, the hypoxic
response was also endothelium-dependent, but was abolished by L-NAME
and ODQ, suggesting the involvement of cyclic GMP. Assay of the cyclic
GMP content showed no change upon exposure to hypoxia in preparations
with and without endothelium. These experiments suggest that these hypoxic
coronary contractions depend on more than one signaling pathway.

OC2.
H E I G H T E N E D S Y S T E M I C OX I DAT I V E S T R E S S
C R I T I C A L LY A C C E L E R AT E S W O R S E N I N G
ATHEROSCLEROSIS IN THE
LATE CARDIOVASCULAR CONTINUUM
YH Chan, KK Lau, KH Yiu, SW Li, S Tam, CP Lau, HF Tse
Division of Cardiology, Department of Medicine, The University of Hong
Kong, Queen Mary Hospital, Hong Kong SAR, China
Background: Both increased oxidative and inflammatory stresses are
implicated in atherogenesis. However, little is known about their role in
atherosclerotic progression in patients already at the advanced cardiovascular
continuum.
Objective: To investigate the impact of oxidative and inflammatory stress
on the progression of carotid atherosclerosis in patients with established
ischemic stroke.
Methods: A total of 43 consecutive patients (mean age 65.7±8.8 years; male
70%) with primary or recurrent ischemic stroke (>6 months) were recruited
from our medical outpatient clinics. High resolution ultrasound (Agilent
Sonos 5500, Philips, USA) was used to assess burden of carotid
atherosclerosis in terms of maximum intima-media thickness (mIMT). Serum
malodialdehyde (MDA) and high-sensitivity C-reactive protein (hsCRP) were
respectively measured as markers of systemic oxidative and inflammatory
stress.
Results: These patients showed a mean mIMT of 2.25±0.98 mm. Serum
MDA (Pearson r=0.32, P=0.035) and hsCRP (Pearson r=0.41, P=0.007)
were both positively associated with mIMT. Adjusting for potential
confounders by multivariate model (age, gender, hypertension, diabetes
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mellitus, hyperlipidemia, smoking history, use of aspirin/statins/
antihypertensives and body-mass index), each 1 µM increase in serum MDA
independently predicted increase in mIMT by 0.79 mm (95%CI [0.231.36], P=0.008). Furthermore, each 1 mg/L increase of hsCRP was
independently predictive of increase in mIMT by 0.06 mm (95%CI [0.010.12], P=0.017). Hyperlipidemia and diabetes accounted for IMT increase
by 0.56 mm (95%CI [0.04-1.08], P=0.037) and 0.53 mm (95%CI [0.011.05], P=0.046) respectively.
Conclusions: This study demonstrated that systemic oxidative stress strongly
accelerates secondary progression of carotid atherosclerosis in patients with
established ischemic stroke, independent of and above all conventional risk
factors including systemic inflammation. This suggests that effective
reduction of oxidative stress should be a major therapeutic target in patients
at the advanced cardiovascular continuum.
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CONTROL OF ADENOSINE FORMATION BY VASCULAR
ENDOTHELIAL CELLS
GY Le, HM Chiu, HJ Ballard
Department of Physiology & Institute of Cardiovascular Science and Medicine,
The University of Hong Kong, Hong Kong SAR, China
Introduction: Adenosine is formed extracellularly by ecto-5'-nucleotidase
(5'N) during exercise vasodilation. It has been suggested that vascular
endothelial cells act as a source of adenosine during hypoxia. However, it is
not known whether the adenosine originating from endothelial cells is formed
intracellularly by cytosolic-5'-nucleotidase or extracellularly by ecto-5'nucleotidase.
Objectives: In this study, we investigated whether vascular endothelial cells
were capable of forming adenosine intracellularly in sufficient quantities for
it to diffuse out into the extracellular space.
Methods: Vascular endothelial cells from hindlimb muscles of young male
SD rats were isolated and purified. In the first series of experiments, cells
were homogenised, and the cytosolic- and ecto-5'Ns were separated by
differential centrifugation. 5'N in the cell homogenates was assayed at different
pH values, as previously reported (Le & Ballard, 2007). Enzyme kinetic
parameters, such as Vmax, Km and Kcat were calculated using the EadieHofstee equation. In the second series of experiments, the cultured primary
endothelial cells were exposed to normoxia or hypoxia (19% or 2% O2) or pH
6.0 for 24 hours. The effects of hypoxia or low pH on the accumulation of
adenosine in the culture medium were determined using HPLC.
Results: The highest value of Vmax occurred at pH 7.5 for ecto-5'N and at pH
7.0 for cytosolic-5'N, but the Vmax for the cytosolic-5'N was 2-3 times higher

than that for the ecto enzyme across the pH range 6.0-8.0. The Km for both
enzymes decreased with pH. Thus, Kcat for both enzymes was increased at
low pH. Accumulation of adenosine in the medium surrounding the cultured
endothelial cells was not changed greatly by a reduction in the pH to 6.0, but
it was increased by around 50% following 24 hours exposure to hypoxia;
preliminary data suggest that AOPCP, an inhibitor for ecto-5'N, did not
significantly decrease the formation of adenosine in hypoxia.
Conclusions: Cytosolic-5'N has a higher activity than ecto-5'N, which is the
opposite of the situation in muscle cells, suggesting that adenosine may be
formed intracellularly in vascular endothelial cells. Furthermore, hypoxia
significantly increased the adenosine formation by primary endothelial cells,
confirming the capability of vascular endothelial cells to form adenosine during
hypoxia.
Reference: GY Le, HJ Ballard. Properties of Adenosine-Metabolising Enzymes
Extracted from Vascular Endothelial Cells. J HK Coll Cardiol 2007;15(2):85.

OC4.
ADIPOCYTE-FATTY ACID BINDING PROTEIN (A-FABP)
I S P R E S E N T I N T H E E N D OT H E L I U M O F M A L E
APOLIPOPROTEIN E-KNOCKOUT MICE

presence of endothelial dysfunction at 8 weeks suggests that the presence
of A-FABP at an older age is a consequence rather than a cause of the
insufficient production of nitric oxide.

MYK Lee,1 PM Vanhoutte,1 Aimin Xu2
1
Department of Pharmacology, 2Department of Medicine, LKS Faculty of
Medicine, The University of Hong Kong, Hong Kong SAR, China
Adipocyte-fatty acid binding protein (A-FABP) modulates inflammatory
responses in macrophages. A-FABP has been detected in cell cultures derived
from porcine regenerated endothelium. These findings suggest a role for AFABP in the formation of foam cells and atherosclerotic plaques. The present
experiments were designed to investigate the presence (or not) of A-FABP
and endothelial function in aortae of 8,12 and 16 weeks old male C57 (strain:
B6.129P2) apolipoprotein E-knockout (ApoE-/-) mice. A-FABP was detected
by immunohistochemical staining in the endothelial layer of the aorta at 12,
but not 8 weeks. Endothelium-dependent relaxations were measured in a
myograph and compared to those obtained in aortae of C57 wild type mice.
The relaxations to acetylcholine were reduced significantly in the ApoE-/mice from 8 weeks on while those to the calcium ionophore A23187 were
diminished significantly only from 12 weeks on. The endotheliumindependent relaxation in response to the nitric oxide donor sodium
nitroprusside was not affected in ApoE-/- mice. In conclusion, A-FABP was
detected in male atherosclerotic-prone C57 ApoE-/- mice since the age of 12
weeks. Endothelial dysfunction was observed as early as at 8 weeks of age
to judge from the reduced endothelium-dependent relaxations to
acetylcholine. The dissociation between the absence of A-FABP and the
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GENISTEIN ACUTELY POTENTIATES ACETYLCHOLINEINDUCED RELAXATION THROUGH A G-PROTEIN
COUPLED PATHWAY IN SPONTANEOUSLY HYPERTENSIVE
RATS
AHY Lin, GPH Leung, SWS Leung, RYK Man
Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong SAR, China

Conclusion: These results demonstrate that rapid vascular actions of genistein
in modulating ACh-induced relaxation and contraction responses in SHR are
mediated by non-genomic pathways. Gαi and Gαq, but not Gαs, were involved
in the potentiating effect of genistein in ACh and A23187-induced relaxations,
but none were involved in the inhibitory effect of genistein in ACh and A23187induced contractions. Involvement of G-proteins in the enhancement of AChinduced relaxation by genistein suggests that genistein exerts its effect through
a putative G-protein coupled phytoestrogen receptor.

Objectives: Genistein, a phytoestrogen rich in soy beans and soy products,
was reported to be a vasorelaxant. This study examined the receptor and related
signaling pathways in the rapid vascular actions of genistein.
Methods: Isometric tension was measured in isolated aortic rings from 32weeks-old male spontaneously hypertensive rats (SHR).
Results: Acute exposure to genistein at 10 µM, a concentration with no direct
relaxation effect, potentiated acetylcholine (ACh)-induced relaxation and
reduced ACh-induced contraction in the presence of L-NAME (100 µM). Both
actions were insensitive to 10 µM actinomycin D (transcription inhibitor) and
10 µM cycloheximide (translation inhibitor). The potentiation of ACh-induced
relaxation by genistein in the absence or presence of indomethacin was
inhibited by 10 µM NF023 and 10 µM GP antagonist-2A, the selective Gi and
Gq α-subunit antagonists, respectively, but not by 10 µM NF449, a selective
Gs α-subunit antagonist. Interestingly, NF023, NF449 and GP antagonist-2A
did not alter the inhibitory effect of genistein on ACh-induced contraction. To
further elucidate the mechanism of the vascular response given by genistein,
the involvement of G-proteins was inspected in A23187-induced relaxation
and contraction. NF023 and GP antagonist-2A, but not NF449 inhibited the
potentiating effect of genistein on A23187-induced relaxation in the presence
of indomethacin. Reduction of A23187-induced contraction by genistein was
unaffected by all three G-protein inhibitors.

OC6.
ESTROGEN SUPPRESSES THE CA 2+ /CALMODULINDEPENDENT PROTEIN KINASE II THUS CONFERRING
CARDIOPROTECTION
Y Ma, WT Cheng, S Wu, TM Wong
Department of Physiology, The University of Hong Kong, Hong Kong SAR,
China

reversed not only by estrogen replacement, but also by blockade of CaMKII
with a selective inhibitor, KN93 (2.5 µM). The observations indicated that
estrogen confers cardioprotection by suppressing the CaMKII. The CaMKII
isoform involved may be CaMKIIδ. The effect of estrogen on CaMKII is
independent of β-adrenoceptor in addition to its effect of down-regulating
the receptor.

Estrogen confers cardioprotection by down-regulating β1-adrenoceptor and
suppressing the expression and activity of protein kinase A. We hypothesized
that estrogen may also protect the heart by suppressing the Ca2+/calmodulindependent protein kinase II (CaMKII), another signaling messenger activated
by β 1-adrenoceptor via the Gs protein that enhances apoptosis. We first
determined the expression of CaMKII in the heart of sham operated rats and
ovariectomized rats with and without estrogen replacement. Both CaMKIIδ
and phosphorylated CaMKII were up-regulated in the heart from
ovariectomized rats, which was restored to normal by estrogen replacement.
We then determined the injury and contractile responses to ischemic insult
with or without β-adrenoceptor stimulation with isoprenaline (10 -7M) in
isolated perfused hearts and isolated ventricular myocytes. The infarct size
and lactate dehydrogenase release from the heart in response to ischemic
insult were significantly greater after ovariectomy. Similarly the cardiac
contractility, the amplitude of the electrically induced intracellular Ca 2+
transient, which is directly correlated to the shortening of the myocyte, and
TUNEL-positive cells, were also greater in the ovariectomized rats upon
ischemia/reperfusion in the presence or absence of isoprenaline. Most
importantly, the responses to ischemic insult in ovariectomized rats were
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ACUTE SIMVASTATIN INHIBITS THE IKATP CHANNELS
OF PORCINE CORONARY ARTERY SMOOTH MUSCLE
CELLS
SW Seto,1 Alice LS Au,1 Rachel WS Li,2 Rebecca KY Lee,1 SW Chan,3
George PH Leung,2 SK Kong,4 Aaron HP Ho,5 John HK Yeung,1 S Wan,6
YW Kwan1
Departments of 1Pharmacology, 4Biochemistry, 5Electronic Engineering and
6
Surgery, The Chinese University of Hong Kong and 2 Department of
Pharmacology, The University of Hong Kong, and 3Department of ABCT,
The Hong Kong Polytechnic University, Hong Kong SAR, China

ouabain (10 µM), in [glucose] o-free and in [Na +] o-free conditions. The
enhanced phospho-AMPKα-Thr172 expression was abolished by compound
C, ryanodine (100 µM), KN93 (10 µM) and in [Ca2+]o-free conditions. Acute
simvastatin enhances glucose uptake and ATP formation which resulted in
an inhibition of PP2A-Tyr307. PP2A inhibition favored the subsequent Ca2+/
CaMKK-mediated AMPKα-Thr172 phosphorylation and thus inhibition of
the vascular IKATP channels opening.
Acknowledgements: This project was financially supported by RGC
Earmarked Grants of Hong Kong (Project code: 2140565).

Statins (3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase
inhibitors) have been shown to provide beneficial effects on cardiovascular
system. Compared to the cholesterol-lowering properties, the effects of
simvastatin (a commonly-used statin) on ion channel gatings of coronary
artery smooth muscle cells have not been fully explored. In porcine isolated
coronary artery, the cromakalim (10 nM-10 µM)- and pinacidil (10 nM10 µM)-induced relaxation was inhibited by simvastatin (3 and 10 µM). In
single cells of human left internal mammary artery and porcine coronary
artery, simvastatin (1, 3 and 10 µM) suppressed the cromakalim (10 µM)and pinacidil (10 µM)-mediated opening of the whole-cell IKATP channels,
and it was eradicated by okadaic acid (100 nM). Simvastatin (10 µM) and
AICAR (1 mM) elicited a compound C (1 µM)-sensitive [3H]-deoxy-glucose
uptake and an increase in [ATP]i of the coronary arterial cells. Simvastatin
caused a time- and concentration-dependent increase in phospho-AMPKαThr172 and phospho-PP2A-Tyr307. Simvastatin-induced phospho-PP2A-Tyr307
was eradicated by okadaic acid, ryanodine, KN93, phloridzin (1 mM),

OC8.
POLYOL PATHWAY CONTRIBUTES TO THE IMPAIRMENT
OF CALCIUM HOMEOSTASIS IN POST-ISCHEMIC
REPERFUSED RAT HEARTS
WH Tang,1 Gennadi M Kravtsov,1 Martina Sauert,1 TM Wong,1 Sookja K
Chung,2 Stephen SM Chung1
1
Department of Physiology & 2Department of Anatomy, Faculty of Medicine,
The University of Hong Kong, Hong Kong SAR, China
A number of studies have shown that the polyol pathway contributes to
ischemia-reperfusion (I/R)-induced myocardial infarction due to depletion
of ATP. However, whether this glucose metabolic shunt also contributes to
I/R-induced cardiac contractile dysfunction is not clear. In the present study,
we show that post-ischemic contractile functions of the isolated perfused
hearts was improved by pharmacological inhibition of aldose reductase (AR)
or sorbitol dehydrogenase (SDH), two enzymes in the polyol pathway. I/Rinduced contractile dysfunction is most likely due to impairment in Ca2+
signaling as indicated by lower amplitude of the Ca2+ peak, longer time to
reach the peak, and slower return to base level. All these abnormalities were
significantly ameliorated by treatment with AR or SDH inhibitors.
Furthermore, we show that inhibition of AR or SDH protected the activity
of SERCA and RyR, two of the key players in Ca2+ signaling mechanism
that regulates cardiac contraction, from I/R-induced inactivation. During
I/R polyol pathway probably contributes to the inactivation of SERCA and
RyR by decreasing the level of GSH and increasing the level of superoxide.
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A CENTRAL ROLE OF PKC∆ AND ACTIVATION OF P38
MAPK AND ERK1/2 PATHWAYS IN ANGIOTENSIN
I I - M E D I AT E D U P R E G U L AT I O N O F C O X - 2 I N
ENDOTHELIAL CELLS
SL Wong, CW Lau, CL Au, X Yao, Y Huang
Institute of Vascular Medicine and Department of Physiology, The Chinese
University of Hong Kong, Hong Kong SAR, China
High circulating angiotensin II (Ang II) levels were reported in patients
with hypertension and other vascular complications, while cyclooxygenase2 (COX-2) has been regarded as the culprit of vascular inflammation and
found to be localized in atherosclerotic plaque. Although both Ang II and
COX-2 are associated with vascular inflammation and remodeling, it remains
elusive whether COX-2 plays a direct role as a downstream event in mediating
Ang II-induced vascular pathogenesis. The present study aimed at
investigating the relations between Ang II stimulation and COX-2 expression
and intracellular signaling pathways linking these two pro-inflammatory
factors. Primary endothelial cells were freshly cultivated from thoracic aorta
of Sprague Dawley rats. The expression level and activation of relevant
proteins with and without drug treatment were examined by Western blot
analysis. COX-2 expression was augmented with increasing Ang II
concentration (3-100 nM), and it reached a maximum (>15-fold increase
compared with control) after an 8-hour incubation with 100 nM Ang II. Ang
II type 1 receptor (AT1R) blocker (losartan) and RNA synthesis inhibitor
(actinomycin-D) inhibited such upregulation. Of the well-known
transcriptional pathways tested, only the inhibitors of p38 MAPK and ERK1/
2 (SB 202190 and PD 98059, respectively) significantly decreased the COX-

2 expression, each producing ~ 50% reduction. Co-treatment with SB 202190
and PD 98059 caused further reduction, suggesting a joint mediation through
p38 MAPK and ERK1/2. Although these signaling molecules are known to
be redox-sensitive, inhibitors of reactive oxygen species (ROS) failed to
alter the COX-2 upregulation. By contrast, PKC inhibitor (GF109203X),
and particularly the specific PKC δ inhibitor (rottlerin), but not PKC α
inhibitor (Go 6976), prevented both the phosphorylation of ERK1/2 and
COX-2 expression. The pivotal role of PKC in Ang II-induced COX-2
expression was further supported by the stimulatory effect of a phorbol ester
(phorbol 12-myristate 13-acetate, PKC activator) on COX-2 expression,
which was again inhibited by GF109203X and rottlerin. The present results
suggest an essential role of PKCδ and subsequent activation of p38 MAPK
and ERK1/2 in Ang II-mediated COX-2 upregulation and this response did
not involve ROS. Since elevated Ang II and COX-2 induction serve as
prerequisites for vascular complications, this study provides an important
molecular basis for further elucidation of how altered COX-2- derived
products participate in vascular inflammation (Supported by GRF 465308,
CUHK Focused Investment Scheme and Li Ka Shing Institute of Health
Sciences).

OC10.
C H RO N I C I N T E R M I T T E N T H Y P OX I A E L E VAT E S
O X I D AT I V E S T R E S S A N D I M PA I R S C A L C I U M
HOMEOSTASIS IN RAT CARDIOMYOCYTES
HM Yeung, MW Hung, Gennadi M. Kravtsov, ML Fung
Department of Physiology, The University of Hong Kong, Hong Kong SAR,
China
Objectives: This study examined the hypothesis that chronic intermittent
hypoxia aggravates oxidative stress and deteriorates calcium (Ca2+)-handling
in rat cardiomyocytes.
Methods: Adult male 2-month old Sprague-Dawley rats were daily
administered with melatonin (MIH, 10 mg/Kg/day of body weight, i.p.) or
vehicle (VIH, 2% ethanol in normal saline) and exposed to intermittent
hypoxia (inspired oxygen alternating from 21 to 5±0.5% oxygen per minute
for 8 hr/day) for 4 weeks. Levels of malodialdehyde (MDA) and the mRNA
expression of anti-oxidant enzymes in the rat hearts were measured
respectively by colorimetric study and reverse transcription-PCR. Changes
in sarcoplasmic reticulum (SR) Ca 2+ -handling were measured by
spectrofluorometric study with isolated fura-2-loaded cardiomyocytes; also
differences in protein levels and activities of SR-Ca2+ handling proteins were
determined by Western blot and 45Ca2+ flux study in the ventricular myocytes.
Results: The ratio of heart/body weight and the level of MDA were
significantly increased in the VIH group compared with the normoxic control
and MIH group. In addition, the mRNA levels of catalase and Mn-superoxide
dismutase in the VIH group were much lower than that of the normoxic and
MIH groups. Furthermore, spectroflurometric studies indicated that decreases
in SR-Ca2+ content and the Ca2+-overloading induced by metabolic inhibition/
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anoxia were remarkable in VIH cardiomyocytes compared to the normoxic
control. Also, protein levels and activities of SR Ca 2+ -ATPase and
sarcolemmal Na + -Ca 2+ exchanger were markedly reduced in VIH
cardiomyocytes. Moreover, these Ca 2+ handling impairments in the
cardiomyocyte were significantly less in the MIH group than that of the
VIH group.
Conclusions: Our results demonstrate that chronic intermittent hypoxia,
simulating severe levels of obstructive sleep apnea in patients, induces
oxidative stress that could cause the impairment of Ca 2+ handling in the
cardiomyocyte leading to cardiac injury.
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A C O M PA R AT I V E S T U D Y O N T H E I S O L AT E D
PANCREATIC b-CELLS OF OBESE (+DB/+DB) AND LEAN
(+DB/+M) MICE
Alice LS Au,1 Rebecca KY Lee,1 SW Seto,1 Ingrid MF Wong,1 SK Kong,2
Aaron HP Ho,5 George PH Leung,3 SW Chan,4 YW Kwan1
Departments of 1Pharmacology, 2Biochemistry and 5Electronic Engineering,
The Chinese University of Hong Kong; 3Department of Pharmacology, The
University of Hong Kong; 4 Department of ABCT, The Hong Kong
Polytechnic University, Hong Kong SAR, China

isopimaric acid (10 µM, a BKCa channel opener) was recorded in the β-cells
of +db/+m mice. In contrast, isopimaric acid did not alter/suppress the K+
current amplitude in the β-cells of +db/+db mice. Thus, our results
demonstrate that the β-cells of +db/+db mice respond differently which may
have significant clinical implications.
Acknowledgements: This project is financially supported by RGC
Earmarked Grant of Hong Kong (Project code: 2140565).

Pancreas plays an important role in glucose homeostasis, insulin secretion
and the development of diabetes mellitus (DM). So far, most type 2 DM
studies were performed on single pancreatic islets and/or β-cells of normal
animals incubated in a specially-designed culture medium that "mimicked"
the hyperinsulinemic/hyperglycemic conditions. However, a successful
isolation of single, viable β-cells from animal models for human DM research
(e.g. obese/diabetic (+db/+db) mice) has not been reported. In addition, a
comparison of the pharmacological responses of single pancreatic β−cells
of the obese/diabetic and lean mice is unknown. In this study, age-matched
(female; ~6 month-old) non-diabetic (+db/+m) (~30 g) and diabetic (+db/
+db) (~60 g) mice were used. Islets of Langerhans of both species were
successfully isolated and the single viable b-cells were harvested. The basal
[Ca 2+] i level and the [Ca 2+] i change in response to ionomycin (2.5 µM)
challenge were significantly smaller in the β-cells of +db/+db mice,
compared to +db/+m mice. Immunofluorescent analysis revealed a lesser
degree of insulin staining in the β-cells of +db/+db mice, compared to +db/
+m mice. An enhanced outward K + current amplitude in response to

P2.
24-HOUR EFFECTS OF BISOPROLOL/
HYDROCHLOROTHIAZIDE COMBINATION COMPARED
WITH VALSARTAN IN CHINESE HYPERTENSIVE
PATIENTS
HB Deng,1 TTW Chu,1 G Cornelissen,2 F Halberg,2 B Tomlinson1
1
Department of Medicine and Therapeutics, The Chinese University of Hong
Kong, Hong Kong SAR, China; 2Halberg Chronobiology Center, University
of Minnesota, Minneapolis, Minnesota, USA
Background and aim: Diuretic-based combination represents an alternative
option for first-line antihypertensive therapy. We compared the efficacy of
β1-blocker bisoprolol with hydrochlorothiazide (Lodoz) with valsartan on
24-hour ambulatory blood pressure in Chinese patients.
Methods: After a placebo run-in, 23 hypertensive patients were randomized
to open-label treatment with once daily Lodoz 2.5 (2.5mg bisoprolol/6.25mg
hydrochlorothiazide) or valsartan 80 mg. Dosage was up titrated every 4
weeks until patients reached target blood pressure (BP). Twenty-four-hour
ambulatory (A) BP monitoring was conducted at weeks 0, 8 and 16. Twentyfour-hour ABP were analysed by time-structured cosinor which involved
the least square fit of a 24-hour cosine curve, estimation of a rhythm-adjusted
mean (MESOR), and measures of the extent and timing of predictable change
within a day (circadian amplitude and acrophase). BP response rate was
defined as the percentage of patients with clinic diastolic (D) BP <90mmHg
or >10mmHg decrease after treatment. Control rate was percentage of patients
with DBP <90mmHg after treatment.

J HK Coll Cardiol, Vol 16

Results: Both Lodoz and valsartan significantly reduced clinic, 24-hour
as well as night-time and day-time BP. Both response and control rates
in the Lodoz group were 100% compared to 72.7% (p>0.05) and 63.6%
(p=0.02) in the valsartan group. The Lodoz group showed significantly
greater reductions in rhythm-adjusted mean of 24-hour DBP (MESORDBP) and daytime DBP than the valsartan group (p<0.05). The MESORBP was decreased by 20.84/12.99mmHg in Lodoz group as compared
with 14.33/7.66mmHg in valsartan group. The Lodoz reduced day-time
BP by 17.81/10.64mmHg and night-time BP by 22.95/14.65 mmHg,
whilst valsartan lowered day-time BP by 11.24/3.93 and night-time BP
by 15.47/10.60 mmHg.
Conclusion:We concluded that the low dose combination of bisoprolol and
hydrochlorothiazide was more effective than valsartan for 24-hour blood
pressure control in terms of MESOR-DBP and day-time DBP.
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INTERMEDIATE CONDUCTANCE CA 2+-ACTIVATED K +
CHANNELS IN PORCINE CORONARY ENDOTHELIUM
UNDER HYPOXIC EXPOSURE
JH Huang,1 Q Yang,1 XQ Yao,2 GW He1
Departments of 1Surgery and 2Physiology, The Chinese University of Hong
Kong, Hong Kong SAR, China

Conclusions: Hypoxia reduces the activity of endothelial IKCa. This may be
an important mechanism underlying the endothelial dysfunction under
hypoxic / ischemic conditions.
Acknowledgments: This study was supported by Hong Kong RGC grant
(CUHK4651/07M) and CUHK direct grants 2041388 & 2041384.

Objectives: The importance of endothelial intermediate conductance Ca2+activated K+ channels (IKCa) in endothelial function has been revealed by
the involvement of these channels in the function of endothelium-derived
hyperpolarizing factor (EDHF) and nitric oxide (NO). Endothelial dysfunction
is observed in many pathological conditions, including hypoxic /
ischemic states. Little is known about the effect of hypoxia on the activity
of IK Ca and therefore, this study was designed to assess whether the
electrophysiological property of IKCa is altered under hypoxic exposure.
Methods: Endothelial cells (ECs) were enzymatically isolated from porcine
coronary arteries. Primary cultures of ECs were used for patch-clamp study.
Hypoxia (PO 2: 25-40 mmHg, 10 min) was elicited in a sealed chamber
bubbling with 95%N2-5%CO2. Whole-cell IKCa currents were compared in
ECs with or without exposure to 1-hr hypoxia.
Results: Hypoxic exposure markedly reduced whole-cell K+ current (21.3±
1.1 pA/pF to 9.8±1.5 pA/pF, at 100 mV, P<0.05) and the current activated
by IKCa /SKCa activator 1-EBIO (from 31.8±3.3 pA/pF to 19.2±2.8 pA/pF,
P<0.05). The inhibitory effect of IKCa blocker TRAM-34 on the current was
more significant in the normoxic group than that in the hypoxic group. IKCa
current was reduced from 12.2±2.0 pA/pF to 1.9±0.4 pA/pF after hypoxic
exposure (P<0.05).

P4.
THE EFFECT OF AGING AND HYPERTENSION ON
ENDOTHELIAL-DERIVED HYPERPOLARIZING FACTOR
(EDHF)-MEDIATED RESPONSES IN SPONTANEOUSLY
HYPERTENSIVE RATS
Billy WC Kong, Susan WS Leung, Ricky YK Man, Paul M Vanhoutte
Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong SAR, China
Aging is accompanied by endothelial dysfunction due to the reduced
bioavailability of nitric oxide (NO) and endothelium-derived hyperpolarizing
factors (EDHF). EDHF-mediated vasodilatation is present in aged or
hypertensive animals. However, it appears impaired in animals when both
conditions are combined. The present study examined the hypothesis that the
release of EDHF is augmented to compensate for a reduced bioavailability of
NO during the early stages of endothelial dysfunction, but that its release is
reduced as endothelial dysfunction progresses. Endothelium-dependent
relaxations to acetylcholine (Ach) were obtained in superior mesenteric arteries
isolated from spontaneously hypertensive rats (SHR) at week 15, week 36,
week 60 and week 72, using age-matched Wistar Kyoto (WKY) rats as controls.
The contribution of EDHF to these relaxations was identified as the residual
response in the presence of the cyclooxygenase inhibitor, indomethacin, and
the NO synthase inhibitor, L-NAME.
Inhibition of the EDHF signaling cascade alone with a combination of TRAM34 and UCL 1684 did not affect ACh-induced relaxations in both SHR and
WKY rats at all ages. The NO-mediated relaxation was comparable in arteries
of both SHR and WKY at all ages. However, in the combined presence of
indomethacin and L-NAME, the ACh-mediated relaxation was reduced in
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arteries of 36 weeks old SHR and abolished at 60 weeks. In arteries of 60
weeks old WKY there was a reduction of the relaxation to acetylcholine. This
EDHF-mediated response was not affected in the presence of the gap junction
inhibitors, carbenoxolone and GAP-27, but, was inhibited in the presence of
the Na+/K+-ATPase inhibitor, ouabain. These findings suggest that under
control conditions NO can fully account for endothelium-dependent relaxations
in mesenteric arteries of SHR and WKY rats. The endothelium releases EDHF
to compensate for NO in the presence of L-NAME in young SHR and WKY
rats. However, the ability of the endothelium to release EDHF is impaired by
aging. In addition, the present results suggest that the Na+/K+ pump but not
gap junctions, are involved in the actions of EDHF in the mesenteric artery of
the rat. The expression and/or activity of these proteins may be reduced by
aging, thus leading to an impaired compensatory EDHF-mediated relaxation
in the absence of NO.
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TISSUE-TYPE PLASMINOGEN ACTIVATOR: A POSSIBLE
C A N D I D AT E O F E N D O T H E L I U M - D E R I V E D
HYPERPOLARIZATION FACTOR?
Idy CY Leung, Paul M Vanhoutte, Ricky YK Man, George PH Leung
Department of Pharmacology, The University of Hong Kong, Hong Kong
SAR, China
It is well established that endothelial cells release endothelium-derived
hyperpolarizing factor (EDHF), which dilates blood vessels. However, the
identity of EDHF has not yet been clearly understood. Tissue-type
plasminogen activator (t-PA) is a serine enzyme secreted by endothelial cells.
It plays a critical role in the regulation of hemostasis by converting
plasminogen into plasmin which initiates fibrinolysis and restricts
propagation of the clot beyond the site of vascular injury. Besides, t-PA is
used in the treatment of acute myocardial infarction because of its fibrinolytic
property. Interestingly, both t-PA and EDHF are released from endothelial
cells upon the stimulation by bradykinin and substance P, and the release
occurs in response to the increase in intracellular calcium concentration.
The aim of the present study was to investigate the vasodilatory effect of
t-PA and whether this effect could account for the EDHF-dependent
vasodilation. The results of tissue bath study showed that exogenously
addition of t-PA elicited dilation of porcine coronary arteries in a dosedependent manner, with an EC 50 value of 0.008 ug/ml. The vasodilatory
effect of t-PA was the same when the endothelial cells were removed,
suggesting that t-PA-induced vasodilation was endothelium-independent.
However, different from EDHF, the vasodilatory effect of t-PA was not
affected by the pretreatment with tetraethylammomiun (a non-selective

potassium channel blocker) and iberiotoxin (a large conductance calciumactivated potassium (BKCa) channel blocker). To study the EDHF response,
porcine coronary arteries were pretreated with L-NAME (which blocks nitric
oxide synthesis) and indomethacin (which blocks prostacyclin synthesis)
before dilation by bradykinin. Our results showed that plasminogen activator
inhibitor-1 (PAI-1), an inhibitor of t-PA, did not change the EDHF response.
In addition, enzyme-linked immunosorbent assay (ELISA) study revealed
that the endogenous release of t-PA from porcine coronary arterial endothelial
cells, upon the stimulation by bradykinin and substance P, was in a negligible
level and was far below the concentration which could cause vasodilation.
We therefore conclude that t-PA can dilate porcine coronary arteries.
However, our data do not support the hypothesis that t-PA is a candidate of
EDHF.

P6.
I N H I B I T I O N O F T H E R E L A X AT I O N TO C N P B Y
ENDOTHELIUM-DERIVED NITRIC OXIDE IN THE
PORCINE CORONARY ARTERY
CF Liang, SWS Leung, KFJ Ng, RYK Man and PM Vanhoutte
Department of Pharmacology, The University of Hong Kong, Hong Kong
SAR, China
C-type natriuretic peptide (CNP) is produced by endothelial cells and has
been proposed as an endothelium-derived hyperpolarizing factor (EDHF).
The present experiments were designed to define the mechanism underlying
relaxations to CNP in coronary arteries and to determine the role of the
endothelial cells in the response. Porcine coronary arteries rings were studied
in organ chambers for isometric tension recording. Concentration-relaxation
curves to CNP were obtained during contractions to prostaglandin F2α or
endothelin-1. The experiments were performed in the absence or presence
of the inhibitor of nitric oxide synthase ω-nitro-L-arginine methyl ester
hydrochloride (L-NAME), the inhibitor of cyclooxygenase indomethacin,
the TP-receptor antagonist S18886 the inhibitor of soluble guanylyl cyclase
ODQ, or a cell permeable analog of cyclic GMP (cGMP). In rings with, but
not those without endothelium, the relaxation to CNP was potentiated
by L-NAME. Incubation with ODQ and cGMP did not affect the response
to CNP. Likewise indomethacin and S18886 did not affect the relaxation.
These experiments suggest that in porcine coronary arteries endotheliumderived NO reduces the relaxation caused by CNP. This effect of NO is not
related to inhibition of soluble guanylyl cyclase or the production of
vasoconstrictor prostaglandins.
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PPARγγ AGONIST ROSIGLITAZONE AMELIORATES
ENDOTHELIAL DYSFUNCTION IN TYPE II DIABETIC (DB/
DB) MICE
XY Tian,1 WT Wong,1 Aimin Xu,2 RL Hoo,2 and Y Huang,1
1
Institute of Vascular Medicine and Department of Physiology, The Chinese
University of Hong Kong; 2Department of Medicine and Pharmacology, The
University of Hong Kong, Hong Kong SAR, China

db/db aortas, and increased phosphorylation of eNOS and AMPK. Taken
together, the present results show that the vasoprotective effect of rosiglitazone
in type II diabetes is mediated through reducing oxidative stress and increasing
NO bioavailability, which may be related to adiponectin-AMPK signaling
cascade. (Supported by GRF grant, CUHK Li Ka Shing Institute of Health
Sciences and CUHK Focused Investment Scheme)

Peroxisome-proliferator-activated receptor (PPAR) agonists have been shown
to exert beneficial effects against vascular disorders including hypertension
and atherosclerosis. PPARγ activation also modulates glucose and lipid
metabolism associated with type II diabetes. The present study investigated
whether chronic PPARγ activation by rosiglitazone could ameliorate
endothelial dysfunction in an animal model of type II diabetes, db/db mice.
db/db mice were treated with rosiglitazone or vehicle for 6 weeks. Plasma
glucose was monitored during the treatment. Plasma metabolic parameters
including insulin, lipid, and adiponectin were determined. Vascular reactivity
in isolated blood vessels was studied in myograph. Protein expressions were
detected by Western blotting. Rosiglitazone treatment significantly improved
endothelium-dependent relaxations in aortas, renal arteries, and resistant
mesenteric arteries of db/db mice. Western blotting results demonstrate a downregulation of angiotensin type I receptor (AT 1 R) and nitrotyrosine.
Rosiglitazone also increased the phosphorylation of eNOS at Ser 1177 and
phosphorylation of 5'AMP-activated protein kinase (AMPK) at Thr172 without
affecting total eNOS or AMPK level. Rosiglitazone significantly improved
glucose tolerance, reduced plasma insulin, total cholesterol, and triglyceride
level. Moreover, rosiglitazone increased the plasma adiponectin level. 12 hrs
treatment of adiponectin in organ culture improved endothelial function in

P8.
LACTIC-ACID-INDUCED ATP RELEASE FROM RAT
SKELETAL MUSCULAR L6 CELLS IS MEDIATED BY
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE
REGULATOR (CFTR) CHANNELS
J Tu, HJ Ballard
Department of Physiology, and Institute of Cardiovascular Science and
Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong
Kong SAR, China
Background and Objective: We had previously shown that lactic-acidinfusion increased the interstitial ATP concentration of perfused rat skeletal
muscle in-vivo, which could be inhibited by CFTRinh-172, a specific inhibitor
of CFTR. A stable rat skeletal muscular L6 cell line was used in this study
to confirm that skeletal muscle cells (rather than nerve or vascular cells)
were responsible for the acidosis-induced ATP release; the role of CFTR in
mediating the ATP efflux during lactic acid incubation was confirmed using
RNA interference (RNAi) technology.
Methods: L6 cells transfected with or without siRNA for the Cftr gene were
incubated with 10 µM lactic acid in the culture medium for 3 hours at 37oC.
At the end of the incubation period, the cells were collected and blotted for
CFTR expression by western blotting technique. HPLC was used to measure
the ATP and adenosine concentrations of the collected bathing medium.
Results: CFTR expression was significantly increased in L6 cells incubated
with 10 µM lactic acid, compared to the cells left untreated. Both CFTR
siRNA(s), which target different sequences of the Cftr gene, suppressed
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CFTR expression in L6 cells. In L6 cells without Cftr gene silencing,
10 µM lactic acid incubation significantly increased extracellular ATP and
adenosine concentrations to a similar extent; however when the CFTR was
suppressed by CFTR siRNA, the lactic-acid-incubation-induced increases
in ATP and adenosine outputs were prevented, suggesting that the increased
ATP was released from L6 cells through CFTR channels during lactic
acidosis, and this ATP was extracellularly converted to adenosine to increase
the extracellular adenosine concentration.
Conclusions: These data confirmed that skeletal muscle cells were the source
for the increased extracellular ATP during a lactic acid challenge; and this
ATP efflux was mediated by CFTR channels.
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CALCIUM-INDEPENDENT PHOSPHOLIPASE A2 INVOLVES
IN ENDOTHELIUM-DEPENDENT CONTRACTIONS IN THE
AORTA OF THE SPONTANEOUSLY HUPERTENSIVE RATS
Michael SK Wong, Ricky YK Man, Paul M Vanhoutte
Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong SAR, China
Phospholipase A2, a regulatory enzyme found in most mammalian cells,
catalyzes membrane phospholipids to arachidonic acid. There are two major
cytosolic types of the enzyme, calcium-dependent (cPLA2) and calciumindependent (iPLA2) phospholipase A2. Calcium plays a crucial role in
endothelium-dependent contractions. The present study investigated whether
or not iPLA2 plays a role in such responses in the aorta of the spontaneously
hypertensive rat (SHR). In endothelial cells, iPLA2 was densely distributed.
At 10 µM, selective iPLA2 inhibitor, bromoenol lactone (BEL), at the
concentration of, abrogated endothelium-dependent contractions induced by
both acetylcholine and A23187. At 5 µM, only the contractions induced by
acetylcholine were inhibited. Incubation with arachidonic acid methyl ester
together with BEL restored the contractions. Same results can be obtained
from the measurement of the release of the prostacyclin. Store-operated calcium
channel (SOC) was also proved to be involved in the contraction process by
using a SOC inhibitor, SKF96365. Thus, iPLA2 plays substantial role in
generating endothelial-derived contracting factors and both calcium-dependent
and -independent pathways areinvolved in the process.

P10.
EFFECTS OF DEXMEDETOMIDINE IN THE MESENTERIC
ARTERY AND THE AORTA OF ENDOTOXIN INDUCED RAT
Emily SW Wong, Ricky YK Man, Paul M Vanhoutte, Kwok FJ Ng
Departments of Pharmacology and Anaesthesiology, Li Ka Shing Faculty
of Medicine, The University of Hong Kong, Hong Kong SAR, China
Introduction: Dexmedetomidine is an anesthetic agent, with known α 2
adrenergic effects, used both in humans and in animals. The present
experiments were designed to compare the vascular effects of dexmedetomidine
in rat arteries during normal and septic conditions.
Methods: Ten weeks old male normal Sprague Dawley rats were used. The
mesenteric arteries and thoracic aortae were dissected and suspended into 5
ml organ chambers for isometric tension recording. In some experiments,
endotoxin from E-coli lipopolysaccharide (O55:B5) was injected 10 mg/kg
intraperitoneally 2 or 24 hours before the start of experiments.
Results: In the mesenteric arteries, dexmedetomidine caused concentrationdependent relaxations (with a maximal response averaging 50%). It induced
smaller relaxations in the rat aorta (maximal response averaging 10%). At
concentrations above 100 nM, the relaxation was reverted to a concentrationdependent contraction in the mesenteric arteries. In the presence of L-NAME
(a nitric oxide synthase inhibitor) and after the removal of the endothelium,
the drug-induced relaxation was abolished in mesenteric arteries. The
secondary contraction was reduced when prazosin (α1 adrenergic antagonist)
was added to the bath solution. After endotoxin administration, the relaxations
in mesenteric arteries were reduced to around 20% in both 2 and 24 hours
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treatment durations. Endotoxin did not affect the magnitude of the secondary
contraction, which were still abolished in the presence of prazosin.
Conclusions: The vascular effects of dexmedetomidine depend on the vascular
bed studied. The vasodilatation caused by dexmedetomidine is nitric oxide
and endothelium-dependent in the rat mesenteric artery. This relaxation can
be reduced during sepsis, while α1 adrenoceptors are responsible for the
secondary contraction at higher concentrations of dexmedetomidine.
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RENIN INHIBITION IMPROVES ENDOTHELIAL FUNCTION
IN SPONTANEOUS HYPERTENSIVE RATS
WT Wong,1 XY Tian,1 M Gollasch,2 Aimin Xu,3 Paul Vanhoutte4, Y Huang1
Institute of Vascular Medicine and Department of Physiology, The Chinese
University of Hong Kong, Hong Kong SAR, China; 2Medical Clinic for
Nephrology and Internal Intensive Care, Charite University Medicine Berlin,
Germany; 3Department of Medicine and 4Department of Pharmacology, The
University of Hong Kong, Hong Kong SAR, China
1

Aliskiren is the first orally effective renin inhibitor approved for the treatment
of hypertension. The present study aims to investigate whether direct renin
inhibition by aliskiren could improve the impaired endothelial function and
NO bioavailability in spontaneous hypertensive rats (SHRs). SHRs and Wistar
Kyoto rats (WKYs) were treated with vehicle (control) and aliskiren for 8
weeks. Blood pressure was monitored biweekly. Changes in vascular reactivity
in isolated aortas and renal arteries were studied in organ bath and myograph.
Protein expression of endothelial nitric oxide synthase (eNOS), angiotensin
II type 1 receptor (AT1R) and nitrotyrosine were detected by Western blot
analysis. Vascular superoxide production was measured by dihydroethidium
(DHE) staining. Blood pressure lowering effect of aliskiren was prominent in
SHRs but not in WKYs. Aliskiren treatment improved endothelial function in
SHRs by restoring the impaired endothelium-dependent relaxations to
acetylcholine and decreasing the exaggerated endothelium-dependent
contractions to acetylcholine in the presence of L-NAME. DHE staining and
western blot on nitrotyrosine revealed the vascular superoxide anions and

peroxynitrite levels were significantly lower in arteries of aliskiren-treated
SHRs. The present results also demonstrate that treatment with aliskiren can
restore the phosphorylation of eNOS at ser1177 without affecting the total eNOS
level, as well as decrease the protein expression of AT1R in SHR arteries. By
contrast, aliskiren has minimal effects on WKYs. Taken together, the present
study provides novel evidence demonstrating that direct renin inhibition can
effectively protect endothelial function in hypertensive rats by augmenting
NO bioavailability, which supports the therapeutic benefit of aliskiren in
patients with hypertension. (Supported by GRF grant, CUHK Li Ka Shing
Institute of Health Sciences and CUHK Focused Investment Scheme)

P12.
I M P ROV E D E N D OT H E L I A L F U N C T I O N I N
SPONTANEOUSLY HYPERTENSIVE RATS STUDY OF
ENDOTHELIAL NITRIC OXIDE SYNTHASE ENHANCER
HM Xue,1 GW He,1 WT Wong,2 XY Tian,2 Y Huang,2 Q Yang1
Departments of 1Surgery and 2Physiology, The Chinese University of Hong
Kong, Hong Kong SAR, China
Objectives: Endothelium-derived nitric oxide (NO) plays a pivotal role in
maintaining vascular homeostasis. NO-deficiency has been demonstrated
in many cardiovascular disorders, including hypertension. We studied
whether AVE3085, a newly developed endothelial nitric oxide synthase
(eNOS) transcription enhancer, improved endothelial function in
spontaneously hypertensive rats (SHR) under both acute and chronic
conditions.
Methods: The isometric force study was performed with rat aortas. Protein
expression of eNOS and phosphorylated eNOS (p-eNOS) was determined
by Western blot. In chronic study, AVE3085 was administrated by oral gavage
once daily for 4 weeks before thoracic aortas were removed. Rats receiving
vehicle (5% methylcellulose) daily for 4 weeks served as control.
Endothelium-dependent relaxation of rat aortas was induced by acetylcholine
(ACh) in phenylephrine-precontraction (n=8).
Results: In the acute study, pretreatment with AVE3085 (10 µM) for 2 hr
markedly increased the ACh-induced relaxation in the aorta of SHR
(50.2±4.5% vs. 26.9±4.4%, P<0.05). eNOS and p-eNOS protein expression
were significantly higher in the SHR treated with AVE3085. Four- week
oral feeding of AVE3085 dramatically reduced the blood pressure in the

67

SHR rats (170.0±4.0 vs. 151.8±1.8 mm Hg, P<0.001) with response to ACh
augmented (50.1±3.4% vs. 19.7±7.0%, P<0.05) in the aorta. Compared with
SHR without AVE3085 treatment, removal of endothelium and L-NAME
pretreatment both enhanced phenylephrine-induced contraction in AVEtreated animals (P<0.05).
Conclusions: The present study demonstrated that AVE3085 improved the
NO-related endothelial dysfunction in SHR and the functional improvement
is associated with the upregulation of eNOS gene expression.
Acknowledgements: This study was supported by Hong Kong RGC grant
(CUHK 4651/07M) and DUHK direct grants 2041388 &2041384.
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P14.

B O N E M O R P H O G E N I C P ROT E I N 4 I N D U C E S
ENDOTHELIAL CELL APOPTOSIS

MULTIPLE ION CHANNEL BLOCK OF CHLOROFORM IS
INVOLVED IN ITS ARRHYTHMOGENIC EFFECT

LH Yung, WT Jack, XY Tian, FP Leung, X Yao, Y Huang
Institute of Vascular Medicine and Department of Physiology, Faculty of
Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong
SAR, China
Expression of bone morphogenic protein 4 (BMP4) can be induced by
disturbed flow and oxidative condition in endothelial cells. BMP4 stimulates
the production of reactive oxygen species (ROS) and causes endothelial cell
dysfunction, leading to some inflammatory diseases, such as atherosclerosis.
However, the molecular mechanism of BMP4-induced endothelial cell
apoptosis was not fully understood. In this study, we investigated the signaling
pathway of BMP4-induced apoptosis in primary cultured rat aortic endothelial
cells (RAECs). Flow cytometry and terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) were used to detect apoptosis. Protein
expressions of caspase-3 and pro-caspase-3 were detected by Western blot.
The production of superoxide anions was detected by dihydroethidium (DHE)
staining. BMP4 induced a time- and concentration-dependent endothelial cell
apoptosis through the release of intracellular superoxide anions and activation
of caspase-3. SB 202190 (p38 MAPK inhibitor), SP 600125 (JNK inhibitor)
but not PD 98059 (ERK inhibitor) inhibit the increase in expression of caspase3 which demonstrates the involvement of p38 MAPK and JNK signaling in
BMP4-induced apoptosis. In conclusion, the present study demonstrates that
release of superoxide induced by BMP4, a novel proinflammatory factor, in
RAECs may trigger p38 MAPK and JNK signalings which then activate
caspase-3 and cause endothelial cell apoptosis. (Supported by GRF and CUHK
Li Ka Shing Institute of Health Sciences and CUHK Focused Investment
Scheme).

Y Zhou,1,2 TM Wong,1 GR Li1,2
Departments of 1Physiology and 2Medicine, Faculty of Medicine, The
University of Hong Kong, Hong Kong SAR, China
Objective: Although chloroform is no longer used in clinic as an anesthetic
due to its acute intoxication leading to lethal arrhythmias as well as depression
of the central nervous system, it is still widely used in industrial production as
organic solvent, and involved in the cases of suicide and homicide. The present
study was designed to investigate the electrophysiological basis of the
arrhythmogenic effect of chloroform.
Methods: Whole-cell patch clamp technique was employed to study effects
of chloroform on inward rectifier K+ channel (Kir2.1), human cardiac ether-ago-go related (hERG) K+ gene, Nav1.5, or pacemaker gene (HCN2) stably
expressed in HEK 239 cells. Isolated rat heart was also used in this study.
Results: Chloroform showed obvious arrhythmogenic effect in isolated rat
heats at a concentration of 10 mM. Although it (10 mM) had no effect on
human cardiac Kir2.1 channels, chloroform inhibited the pacemaker HCN2
channel and human cardiac I Kr (i.e. hERG) channels in a concentrationdependent manner, with IC50 of 4.57 µM and 4.29 µM respectively. The
inhibition of hERG channel was recovered to 78.3% on washout. In addition,
chloroform suppressed human cardiac Nav1.5 currents to 75.5%, 52.4%, and
17.2% of control at 5, 10 and 15 mM, respectively.
Conclusion: These results demonstrate that chloroform blocks multiple cardiac
ion channels, IKr, INa, and the pacemaker HCN2, which likely account at least
in part for the chloroform-induced lethal arrhythmias. These findings may be
helpful in seeking effective treatment of acute chloroform intoxication.

P15.
PROTECTIVE EFFECT OF APIGENIN ON NEURONS
AGAINST CEREBRAL ISCHEMIA/REPERFUSION INJURY
VIA REGULATING THE ACTIVITY OF ATPASE
Lu-Mei Fang, Ming-Ming Zhang, Chun-Lei Yao, Yu-Ting Fang, Qiang Xia,
Xiong Zhang
Department of Physiology, Zhejiang University School of Medicine / Mailbox
17, Zijingang Campus of Zhejiang University, 388 Yuhangtang Road,
Hangzhou 310058, China

rate and the percentage of apoptotic cells in a dose-dependent manner.
Apigenin (200 mg.Pkg-1, i.p.) markedly inhibited the decrease of ATPase
activities induced by global cerebral ischemia/reperfusion.
Conclusion: Apigenin protects neurons against ischemia/reperfusioninduced cell injury via, at least partly, regulating the activity of ATPase.

Objectives: To determine whether apigenin, the main component of Flos
Chrysanthemi, protects neurons against cerebral ischemia/reperfusion injury
and its underlying mechanism.
Methods: Primary cultured hippocampal neurons were prepared from newborn Sprague-Dawley rats, and the model of oxygen-glucose deprivation/
reperfusion (2 h/24 h) was used. Neuronal viability was assessed by 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and
cell injury was evaluated by lactate dehydrogenase (LDH) leakage rate. The
percentage of apoptotic cells was measured by using Hoechst 33258 staining.
Adult male Sprague-Dawley rats were subjected to four-vessel-occlusion
for 10 min followed by reperfusion for 24 h, and the activities of Na+, K+ATPase and Ca2+, Mg2+-ATPase were measured by spectrophotometry.
Results: Oxygen-glucose deprivation/reperfusion decreased the cell viability
and increased LDH leakage rate and percentage of apoptotic cells. Compared
with oxygen-glucose deprivation/reperfusion group, apigenin (1-100 µmol/
L) treatment significantly increased the cell viability, decreased LDH leakage
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INVOLVEMENT OF ION CHANNELS IN PROLIFERATION
OF HUMAN CARDIAC FIBROBLASTS
ML He, Y Zhou, Lau CP, HF Tse, GR Li
Department of Medicine, Li Ka Shing Faculty of Medicine, The University of
Hong Kong, Hong Kong SAR, China

Conclusion: These results demonstrate that IKDR, big conductance IKCa and
ICl.vol, but not I Na, regulate the proliferation of human cardiac fibroblasts.
The further study will be performed using specific siRNAs targeting to
specific ion channel genes to investigate how these channels modulate cell
cycle progression and whether proliferation-related kinases are affected by
these interventions.

Objective: Cardiac fibroblasts play a central role in the maintenance of
extracellular matrix in the normal heart and as mediators of inflammatory
and fibrotic myocardial remodeling in the injured and failing heart. Excessive
fibroblast proliferation and increase in the extra-cellular matrix will increase
myocardial stiffness and cause ventricular dysfunction and subsequent heart
failure. Our previous study demonstrated that four types of ionic currents,
IKDR (voltage-gated delayed rectifier K+ current), IKCa (big conductance Ca2+
-activated K+ current), ICl.vol (volume-activated chloride current), and INa were
present in cultured human cardiac fibroblasts. Little is known about the
functional involvement of these ion channels in cardiac fibroblasts, and the
present study was therefore designed to examine the possible involvement
of IKDR, IKCa, ICl.vol, and INa in proliferation of human cardiac fibrioblasts.
Methods and results: Using MTT assay, we found that cell proliferation of
human cardiac fibroblasts was remarkably suppressed the I KDR blocker
4-aminopyridine (3.0 mM, by 27.2%, P<0.05 vs vehicle control), the specific
big conductance IKCa blocker paxilline at 1 and 3 µM (by 12.0% and 58.4%,
P<0.05 vs control), and the volume-regulated chloride channel blocker NPPB
(200 µM, by 12.1%, P<0.01) or DIDS (200 µM, by 25.9%, P<0.01 vs control)
with 48 h incubation. However, sodium channel blocker, TTX (1 and 10 µM),
had no significant effect on proliferation of human cardiac fibroblasts.

P17.
ROLE OF MONOAMINE OXIDASES IN THE
EXAGGERATED 5-HT-INDUCED TENSION DEVELOPMENT
IN VITRO OF HUMAN PRE-ECLAMPTIC UMBILICAL
ARTERY
SW Seto,1 HY Lam,1 WS Lau,1 Alice LS Au,1 Stephen SC Chim,2 TY Leung,2
John HK Yeung,1 SK Kong,3 George PH Leung,4 YW Kwan1
Departments of 1 Pharmacology, 2 Obstetrics and Gynaecology,
3
Biochemistry, The Chinese University of Hong Kong; 4Department of
Pharmacology, The University of Hong Kong, Hong Kong SAR, China

were demonstrated in the umbilical artery (endothelium intact) lysate of PE
pregnancy, compared to that of the umbilical artery of normal pregnancy.
Thus, in the umbilical artery of PE pregnancy, a decrease of MAO A and
eNOS protein expression levels is probably associated with, or responsible
for, the exaggerated 5-HT-induced tension development.
Acknowledgements: This project was financially supported by Direct Grants
for Research (The Chinese University of Hong Kong) (Reference no.: 2007.
1.079).

We investigated the role(s) of monoamine oxidases (MAOs) on the altered
5-hydroxytryptamine (5-HT)-induced tension development of the isolated
umbilical artery of preeclamptic (PE) pregnancy of Chinese women. An
enhanced 5-HT-induced tension development of the umbilical artery of PE
pregnancy was observed when compared with that of normal pregnancy.
The enhanced component of 5-HT-induced tension development was
eradicated by clorgyline (a MAOA inhibitor). Blockade of eNOS (Nω-nitroL-arginine methyl ester), 5-HT transporter (citalopram) and 5-HT receptor
subtypes (5HT2B, SB 204741; 5-HT2C, RS 102221; 5-HT7, SB 269970) of
the umbilical artery of normal pregnancy mimicked the enhanced 5-HTinduced tension development as observed in the PE tissues. In contrast, no
apparent changes in 5-HT-induced tension development of the umbilical
artery of PE pregnancy were observed with the same pharmacological
manipulations. A decreased protein expression levels of MAOA and eNOS
(no iNOS expression was detected), and an increased expression of PTEN
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EFFECTS OF HIGH GLUCOSE (25 MM) ON HMG COA
REDUCTASE AND CAVEOLIN-1 PROTEIN EXPRESSION IN
PORCINE ISOLATED PANCREATIC ISLETS
SW Seto,1 HY Lam,1 WS Lau,1 Carman Lo,1 Elco PS Wong,1 Alice LS Au,1
Ingrid MF Wong,1 SK Kong,2 George PH Leung,3 SW Chan,4 YW Kwan1
Departments of 1Pharmacology and 2Biochemistry, The Chinese University
of Hong Kong; 3Department of Pharmacology, The University of Hong Kong;
4
Department of ABCT, The Hong Kong Polytechnic University, Hong Kong
SAR, China

and 48 hr). Thus, our results suggest that hyperglycaemia has significant
modulatory effects on HMG CoA reductase expression/functions of porcine
pancreatic islets. The physiological significance of HMG CoA reductase in
diabetes mellitus remains to be determined.
Acknowledgements: This project is financially supported by RGC
Earmarked Grant of Hong Kong (Project code: 2140565).

Recent studies have demonstrated that inhibition of HMG CoA reductase
by statins inhibited the glucose-induced insulin release in various animal
models, and uses of statins provide beneficial outcomes in diabetic patients.
However, the biochemical existence of HMG CoA reductase in the pancreas,
and the effects of hyperglycaemia on HMG CoA reductase are unknown. In
this study, we hypothesised that glucose levels modulate the expression of
HMG CoA reductase and caveolin-1 in porcine isolated pancreatic islets.
Fresh pancreatic islets were harvested and incubated in medium
supplemented with normal (5 mM) or high (25 mM) glucose for 24 and 48
hr before subjecting to Western blot analysis. Our results demonstrate, for
the first time, the expression of HMG CoA reductase in porcine isolated
pancreatic islets. Under high glucose (25 mM) conditions (48 hr), a
significant increase and decrease of the expression of HMG CoA reductase and
caveolin-1, respectively, were observed. In contrast, there was apparent
change in the expression of HMG CoA reductase and caveolin-1 of the
pancreatic islets incubated under the normal glucose (5 mM) conditions (24

P19.
SIMVASTATIN SUPPRESSES CYTOKINES-INDUCE INOS
EXPRESSION IN PORCINE ISOLATED PANCREATIC ISLETS
SW Seto,1 Alice LS Au,1 HY Lam,1 WS Lau,1 Carman Lo,1 Elco PS Wong,1
Ingrid MF Wong,1 SK Kong,2 George PH Leung,3 SW Chan4 and YW Kwan1
Departments of 1Pharmacology and 2Biochemistry, The Chinese University
of Hong Kong; 3Department of Pharmacology, The University of Hong Kong;
4
Department of ABCT, The Hong Kong Polytechnic University, Hong Kong
SAR, China

IL-1β and TNF-α regulated iNOS expression of porcine isolated pancreatic
islets which was sensitive to the presence of simvastatin. Acknowledgements:
This project is financially supported by RGC Earmarked Grant of Hong Kong
(Project code: 2140565).

Inflammation is important in the pathophysiology of diabetes mellitus.
Inflammatory cytokines such as IL-1β, TNF-α and INF-γ induced iNOS
expression and inhibited insulin secretion from the pancreatic islets of various
animal models. Statins (HMG CoA reductase inhibitors) possess antiinflammatory effects but the effects of statins on the inflammatory cytokinesinduced iNOS expression of the pancreatic islets are unknown. In this study,
we hypothesised that simvastatin (a HMG CoA reductase inhibitor) modulates
the cytokines-induced iNOS expression of freshly harvested porcine isolated
pancreatic islets. The harvested pancreatic islets were incubated with or without
IL-1β (10 ng/ml) and TNF-α (10 ng/ml), alone or in combination, for 24 hr.
In some preparations, the islets were pre-incubated with simvastatin (10 µM;
60 min) before the addition of cytokines. The protein expression of iNOS of
the pancreatic islets was evaluated and compared. IL-1β and TNF-α, applied
alone, failed to induce iNOS protein expression. In contrast, a combination of
IL-1β and TNF-α markedly induced iNOS expression which was significantly
suppressed by simvastatin. Thus, we have demonstrated that a combination of

J HK Coll Cardiol, Vol 16

October 2008

70

ICSM, THE TWELFTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Posters:
P20.
PROTECTIVE EFFECTS OF RALOXIFENE AND ESTROGEN
ON RAT PROSTATE ENDOTHELIAL CELL LINE YPEN-1
DAMAGED BY HYPOXANTHINE-XANTHINE OXIDASE
(HXXO) OXYGEN RADICAL DONOR SYSTEM
FP Leung,1 XG Shi,2 H Wang,3 HF Kung,3 Y Huang1
1
Institute of Vascular Medicine and Department of Physiology, The Chinese
University of Hong Kong, Hong Kong SAR, China; 2Department of Neurology,
First Affiliated Hospital Sun Yat-sen University of Medical Sciences, 58
Zhongshan Road II, Guangzhou, 510080, China; 3Center of Emergency and
Infectious Disease, Molecular Biology Laboratory, The Chinese University
of Hong Kong, Hong Kong SAR, China
Reactive Oxygen Species (ROS) have been traditionally regarded as toxic
by-products of aerobic metabolism. ROS, however, also act as intracellular
signaling molecules and can mediate phenotypes in vascular endothelial
cells, which may be physiological or pathological in nature. Estrogen has
been demonstrated to protect different types of cells from apoptosis induced
by various substances. Selective estrogen receptor modulators (SERMs) such
as raloxifene are compounds that have both estrogen agonistic and estrogen
antagonistic properties. They can function in the same way as estrogen in
some tissues (e.g. bone) and more like antiestrogen in some other tissues
(e.g. breast) and have important clinical applications. This study is to examine
the effects of estrogen and raloxifene on the HX-XO (hypoxanthinexanthine)-induced death of rat prostate endothelial cell line YPEN-1 and
the mechanism of its protective effects. MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide] assay showed that in the control group,

cell survival rate decreased significantly. After DAPI staining, in the estrogen
and raloxifene-pretreated group the number of cells with apoptotic
morphology decreased significantly. The mechanism of estrogen and
raloxifene protection was studied using two-dimensional gel electrophoresis
coupled with mass spectrometry. In comparison with controls cells, the
differential proteomic analysis of YPEN-1 treated by HX-XO revealed the
variation of some proteins such as rab GDP dissociation inhibitor β-2, histone
H2B, alcohol dehydrogenase, peroxiredoxin, adenylate kinase isoenzyme,
dihydrolipoyllysine-residue acetyltransferase component of pyruvate
dehydrogenase complex, protein disulfide-isomerase A6 and peptidyl-prolyl
cis-trans isomerase A. Raloxifene and estrogen were shown to restore the
altered proteins to the control level. These proteins induced by estrogen or
raloxifene might play an important role in protecting endothelial cells from
oxidative stress-induced cellular damage. (Supported by GRF grant, CUHK
Li Ka Shing Institute of Health Sciences and CUHK Focused Investment
Scheme).

P21.
INHIBITORY EFFECTS OF NON-STEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) ON NUCLEOSIDE
TRANSPORTERS IN HUMAN AORTIC SMOOTH MUSCLE
CELLS
GPH Leung,1 RWS Li,1 SW Seto,2 YW Kwan2
Department of Pharmacology, The University of Hong Kong; 2Department
of Pharmacology, The Chinese University of Hong Kong, Hong Kong SAR,
China
1

Objective: It is known that the equilibrative nucleoside transporters (ENTs)
play an important role in adenosine functions because they fine-tune the
extracellular concentrations of adenosine. Non-steroidal anti-inflammatory
drugs (NSAIDs) are commonly used in the treatment of pain and inflammation.
NSAIDs affect vascular functions due to their inhibitory effect on
cyclooxygenase, which attenuates the synthesis of vasoactive prostanoids. In
the present study, we sought to investigate whether or not NSAIDs could act
on ENTs in vascular smooth muscle cells.
Methods: The ENT activity in human aortic smooth muscle cells (HASMCs)
was determined by measuring the initial rate of [3H]adenosine uptake. Since
ENTs can be subdivided into ENT-1 and ENT-2, the effects of NSAIDs on
these specific isoforms will also be studied using PK15NTD/ENT-1 and
PK15NTD/ENT-2 cells.
Results: The effects of different NSAIDs (100 µM) on [3H]adenosine uptake
were screened. Aspirin and naproxen had no effect on [3H]adenosine uptake.
Etodolic, ibuprofen and ketoprofen inhibited [3H]adenosine update by 15%
while indomethacin, mefenamic acid and piroxicam inhibited adenosine uptake
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by 30%. Sulindac inhibited [3H]adenosine uptake by 20% but its active
metabolites sulindac sulfide and sulindac sulfonate inhibited [3H]adenosine
uptake by 80% and 30%, respectively. Sulindac sulfide inhibited [3H]adenosine
uptake in PK15NTD/ENT-1 cells with IC50 values of 22.6 ± 3.35 µM and
kinetic study revealed that sulindac sulfide was a competitive inhibitor of
ENT-1. In contrast, sulindac sulfide did not affect the [3H]adenosine uptake
in PK15NTD/ENT-2 cells.
Conclusions: Among the NSAIDs studied, sulindac sulfide appears to be the
most potent in inhibiting the ENT-1-mediated adenosine uptake in HASMCs.
It suggests that sulindac sulfide may affect the vascular functions through its
potential effect on regulating the availability of adenosine in the vicinity of
adenosine receptors.
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E F F E C T O F 2 ' , 3 ' - D I D E OX YA D E N O S I N E O N T H E
RELAXATION OF RAT BASILAR ARTERIES
RWS Li, GPH Leung
Department of Pharmacology, The University of Hong Kong, Hong Kong
SAR, China
Objective: 2',3'-Dideoxyadenosine (ddA) is a nucleoside analogue, which is
used as an antiviral drug for HIV-infected patients. At the same time, ddA is
an inhibitor of adenylyl cyclase. It has been suggested that ddA reduces
vasodilation in rabbit iliac arteries because ddA decreases cAMP level in
endothelial cells, which in turn inhibits gap junction and reduces the
endothelium-dependent hyperpolarization factor (EDHF) response (Griffith
et al., 2004). However, evidence has demonstrated that EDHF responses in
other vascular beds are not necessarily linked to gap junction. Therefore, it is
hypothesized that ddA may show different effects on different types of blood
vessels.
Methods: The effect of ddA on rat basilar arteries was investigated using
wire myograph.
Results: Pre-incubation of ddA did not affect the acetylcholine-induced
endothelium-dependent relaxation of basilar arteries. In contrast, ddA itself
caused relaxation of basilar arteries in a dose-dependent manner (2 x 10-6-2 x
10-4 M). The vasorelaxing effect of ddA was unaffected even the endothelium
was removed. In addition, although ddA is an adenosine analogue, the
vasorelaxing effect of ddA was not inhibited by ZM 241385 (1 x 10-6 M, an
adenosine receptor blocker).

Conclusion: The present findings have demonstrated that the effect of ddA
on rat basilar arteries is distinct from that on rabbit iliac arteries. ddA reduces
vasodilation in rabbit iliac arteries but exerts vasorelaxing effect on rat basilar
artery through an endothelium-independent and adenosine receptorindependent mechanism.
Reference: Griffith TM, Chaytor AT, Edwards DH, Daverio F, McGuigan C.
Enhanced inhibition of the EDHF phenomenon by a phenyl methoxyalaninyl
phosphoramidate derivative of dideoxyadenosine. Br J Pharmacol 142: 2730; 2004.

P23.
MOLECULAR MECHANISM AND CHARACTERIZATION OF
MATERNALLY INHERITED ESSENTIAL HYPERTENSION
Wang Shiwen, Li Zongbin, Liu Yuqi, Zhu Haiyan, Li Yang, Li Yanhua, Wang
Hao, Zhu Mei, Wen Yi
Institute of Geriatric Cardiology, Chinese PLA General Hospital, Beijing,
China
Objective: We aimed to observe the relationship between the mitochondrial
tRNA mutation and the essential hypertension by examining the mutation of
four tRNA (tRNALys, tRNAIle, tRNAGln and tRNAMet). We also wanted to explore
the inherited signs and clinical characters of maternally inherited essential
hypertension.
Methods: We collected the data of general information, blood routine test,
blood biochemical examination and color Doppler echocardiography
examination of the subjects. We extracted DNA from subject's white blood
cell, and amplificated the target fragment using the special primers. We then
purified the PCR products, and then we directly sequenced them. At last, we
analysised the sequencing results and blasted it on net. We also made a
comparative analysis of the collected data of the essential hypertension subjects
who carried tRNA mutation and those who did not carry mutation using the
methods of 1:1 case-control study.
Results: (1) From the mutation analysis of mitochondrial DNA of 2,000
essential hypertensive subjects, we totally found 26 mutation sites in 57
subjects, and 22 mutation sites were new. The most frequently occurrence of
the mutation site was A4386G in tRNAGln gene, next to this was G4394A in
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the same tRNA gene. (2) The onset ages of the individuals carrying the mutation
were earlier than those who did not bear them, which was not associated with
the change of body mass index. (3) tRNA mutations significantly affected
serum lipids, blood electrolyte, blood creatinine, blood urea nitrogen and heart
structure and function, and different tRNA mutations produced different
effections. (4) Most essential hypertensive patients had maternally inherited
history, which fulfilled the feature of mitochondrial hereditary.
Conclusion: 1. Mitochondrial tRNA mutations might result in the change of
their structure and function, and then damaged the blood metabolism, the
balance of the blood electrolyte, the steady-state of the blood cells and the
heart structure and function, which were involved in the progress of the
essential hypertension. (2) Part of the essential hypertension patients clinically
presented the characters of maternal inheritance, which might be associated
with the tRNA mutation.
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UP-REGULATION OF ENDOGENOUS NITRIC OXIDE
PRODUCTION IN RAT ADRENAL GLAND IN CHRONIC
HYPOXIA
Y Liu, CF Lau, KM Ng, ML Fung
Department of Physiology, The University of Hong Kong, Hong Kong SAR,
China

gland was also increased in the CH group. Comparable results were observed
in PC12 cells.
Summary: Chronic hypoxia upregulates the NOS expression and endogenous
NO production in rat adrenal glands. The elevated NO production in the adrenal
gland may play patho- or physiological roles in the activation of sympatheticadrenal axis in responding to chronic hypoxia.

Background: Adrenal gland is an effector of the sympathetic nervous system,
which plays an important role in the cardiovascular response to hypoxia. We
have shown the endogenous nitric oxide (NO) produced by NO synthases
(NOS) is increased by hypoxia in oxygen-sensitive tissues. Yet, there is a
paucity of information on the adrenal NO production under chronically hypoxic
(CH) conditions simulating in subjects sojourning to high altitude or patients
with chronic cardiopulmonary diseases.
Hypothesis: CH increases the endogenous NO production and the NOS
expression in adrenal gland.
Methods: Normoxic (N) and CH rats were exposed to air and 10% O2 for 7
days, respectively. The level of endogenous NO was measured by
electrochemical microsensor placed on the surface of superfused adrenal gland
slices. The expression of NOS in adrenal gland was determined by RT-PCR
and Western Blot. RESULTS: L-arginine (Arg, 1 mM) increased the adrenal
NO level. The Arg-induced NO elevation was significantly more in the CH
group than that of the N group. By contrast, the endogenous NO level was
decreased by NOS inhibitor L-NMMA (100 µM). The effect of L-NMMA on
the endogenous NO production in CH slices was more significant than that of
the N group. Moreover, the mRNA and protein expression of NOS in adrenal

P25.
VOLTAGE-DEPENDENT ANION CHANNEL IS INVOLVED IN
T H E A P O P TO S I S O F C E L L L I N E S C A R RY I N G
MITOCHONDRIAL DNA A4263G MUTATION
Liu Yuqi,1 Wang Shiwen,1 Li Yang,1 Li Zongbin,1 Xu Hua,2 Wen Yi,1
Wang Lin,1 Guan Minxin3
1
Institute of Geriatric Cardiology, Chinese PLA General Hospital, Beijing,
100853, China; 2Military Medical Science Academy of the Chinese PLA,
Beijing, 100850, China; 3Cincinnati Children's Hospital Medical Center,
Division of Human Genetics, Cincinnati, OH 45229, USA

this difference was attenuated by Cyclosporin A (CsA, 2µM), a blocker of
VDAC. In conclusion, the change of expression of mitochondrial VDAC and
subcellular co-localization of VDAC/Bax leads to the significant increase of
mitochondrial permeability and apoptosis of cell lines carrying mtDNA
A4263G mutations.

In this report, we studied the effect of voltage-dependent anion channel (VDAC)
contributed to the apoptosis of the cell lines carrying mitochondrial DNA
A4263G mutation. We established lymphoblastoid cell lines derived from 3
symptomatic and 1 asymptomatic hypertension individuals in the family
carrying A4263G mutation compared with 3 control cell lines. The
mitochondrial potential (∆Ψm) was detected by flow cytometry and the colocalization of VDAC and Bax was evaluated by confocal laser scanning
microscopy. The results showed that the expression of VDAC and Bax of the
lymphoblastoid cell lines in individuals carrying mtDNA A4263G mutation
increased compared with control group, while the expression of small
conductance calcium dependant potassium (sKCa) had no change. The confocal
imaging showed co-localization of VDAC/Bax on the outer membrane of
mitochondrial of the cell lines from individuals carrying mtDNA A4263G
mutation, while the interaction was not seen on control group. Flow cytometry
showed mitochondrial potential of cell lines from individuals carrying mtDNA
A4263G mutation decreased 32% compared with control group (P<0.05) and
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RELATIONSHIP BETWEEN QRS TIME AND LONG-TERM
EFFECT OF VENTRICULAR RESYNCHRONIZATION IN
ELDERLY
Ciayi Lu, Shiwen Wang, Lei Gao, Wei Yan, Yuexi Wang, Taohong Hu, Peng
Liu, Rui Chen, Jinyue Zhai
The Institute of Geriatric Cardiology, PLA General Hospital, Beijing 100853,
China
Objective: The purpose of the study is to explore the relationship between
QRS time and long-tern effect of ventricular resynchronization in the
treatment of congestive heart failure in elderly.
Methods: Consecutive elderly patients with congestive heart failure were
selected with the criteria of: (1) Sinus rhythm. (2) NYHA 3-4 class. (3)
LVEF<40%. (4) LVED >55mm. (5) delta ventricular ejection time>30ms.
(6) moderate mitral insufficiency. (7) refractory to conservative medication.
NYHA(class)
Wide QRS
Narrow QRS
P value

Control
3.3±1.6
3.1±1.5
>0.05

F/U
2.5±1.2
2.6±1.7
>0.05

Patients were divided into wide (>120 ms) and narrow (<120 ms) QRS group
according to the QRS time on surface electrocardiogram. The parameters of
procedure, pacing and follow-up between two groups were comparable
(P<0.05).
Results: Twenty-seven elderly patients (male 21 cases, mean age 67.3±
5.6years) were enrolled. Sixteen and eleven patients were divided into wide
and narrow QRS groups respectively (176.8±13.2ms vs116.5±8.6ms).
Twenty-seven tri-chamber pacemakers were successfully implanted without
mortality and complications. After procedure, QRS time was shortened by
31.2±5.7ms in wide QRS group and prolonged by 11.4±3.2ms in narrow
QRS group. Two groups were followed by 15.4±3.8 months with event free.
Compared with pre-procedure, both groups had significant improvement in
NYHA, LVEF, LVED and delta ventricular ejection time (P<0.05). There
were no significant different between two groups in above parameters during
follow-up (P>0.05).

LVEF(%)
Control
31.9±7.2
34.2±6.5
>0.05

F/U
47.3±8.6
45.8±7.7
>0.05

LVED(mm)
Control
62.8±5.7
63.2±5.3
>0.05

F/U
47.1±4.9
46.3±5.2
>0.05

Delta ejection time (ms)
Control
46.6±8.9
45.7±6.1
>0.05

F/U
33.6±5.1
31.4±3.9
>0.05

Conclusions: Ventricular resynchronization has long-term improvement
effect in elderly patients with congestive heart failure and selected by delta
ventricular ejection time. QRS time in surface electrocardiogram has no
influence on this long-term effect.

P27.
ANTIARRHYTHMIC EFFECT OF ETHYL ACETATE
EXTRACT FROM FLOS CHRYSANTHEMI ON RATS
Zhi-Guo Ye, Ling-Bo Qian, Xiao-Chen Ru, Shui-Feng Qiu, Wan-Hong Xu,
Qiang Xia
Department of Physiology, Zhejiang University School of Medicine / Mailbox
17, Zijingang Campus of Zhejiang University, 388 Yuhangtang Road,
Hangzhou 310058, China
Objective: To investigate the effect of ethyl acetate extract from Flos
Chrysanthemi (EFC) on experimental arrhythmia induced by ischemia/
reperfusion or aconitine in rats and its underlying mechanisms.
Methods: Arrhythmia model in intact rat was induced by aconitine (30 µg/kg
body weight, i.v.). In isolated Langendorff-perfused rat hearts, regional
ischemia and reperfusion was induced by ligation (for 30 min) and release
(for 15 min) of left anterior descending artery. The effect of EFC on ventricular
fibrillation threshold (VFT), effective refractory period (ERP), and diastolic
excitation threshold (DET) in rat heart was measured. The action potentials of
papillary muscle in rat right ventricle were recorded by conventional glass
microelectrode technique and four parameters including resting potential (RP),
amplitude of action potential (APA), maximal velocity of phase 0
depolarization (Vmax), and action potential duration at 90% repolarization
(APD90) were measured.
Results: We found that (1) EFC significantly decreased the number and
duration of ventricular tachycardia (VT), delayed the occurrence of ventricular
premature beats (VPB) and VT induced by aconitine. Arrhythmia score of the
EFC group was lower than that in aconitine-treated group. (2) EFC markedly
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prolonged the ERP and increased the VFT in the isolated perfused rat hearts
during ischemia and reperfusion, but did not affect the DET. (3) EFC
significantly decreased Vmax, prolonged APD90, but had no effect on RP and
APA in papillary muscle from the right ventricle compared with ischemia/
reperfusion group.
Conclusion: EFC antagonizes the arrhythmia induced by aconitine, and
decreases the vulnerability of I/R myocardium, which may be mediated by
the inhibition of Na+ influx and Na+ channel inactivation kinetics and the
decrease of K + efflux during repolarization, thus increasing myocardial
electrophysiological stability.
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FUNCTIONAL EXPRESSION OF TRANSIENT RECEPTOR
POTENTIAL VANILLOID-RELATED CHANNELS IN
C H RO N I C A L LY H Y P OX I A H U M A N P U L M O NA RY
ARTERIAL SMOOTH MUSCLE CELLS
Jun Wang, Yuexiu Wang, Chen Wang
Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital; Basic
Medical Science College, Capital Medical University, Beijing, China
Transient receptor potential vanilloid (TRPV)-related channels are nonselective
cation channels pertinent to diverse physiological functions. Multiple TRPV
channel subtypes have been identified in different tissues and cloned. The
aim of this study was to investigate the role of TRPV channels in hypoxiainduced proliferation of human pulmonary artery smooth muscle cells
(PASMCs) and its possible signal pathway. RT-PCR, real-time PCR and
Western blot were used to detect the expression of TRPV in human PASMCs.
Cell number was determined with a hemocytometer. Cytosolic Ca 2+
concentration ([Ca2+]cyt) was measured using a dynamic digital Ca2+ imaging
system. The mRNA of TRPV1-4 was detected in human PASMCs and chronic
hypoxia up-regulated expression levels of the TRPV1 gene and protein. The
ability to proliferate, the resting [Ca2+]cyt, and CPA-induced capacitative Ca2+
entry in human PASMCs were enhanced significantly by chronic hypoxia
compared with the control, and these effects were inhibited in a dose-dependent
manner by capsazepine, a TRPV1 channel inhibitor. These results suggested
that TRPV1 may be a critical pathway or mediator in chronic hypoxia-induced
proliferation of human PASMCs.

P29.
A STUDY ON MATERNALLY INHERITED HYPERTENSION
AND MITOCHONDRIAL DNA POINT MUTATION A4263G IN
A LARGE CHINESE FAMILY
Yuqi Liu,1 Shiwen Wang,1 Zongbin Li,1 Haiyan Zhu,1, Yang Li,1 Yusheng Zhao,1
Caiyi Lu,1, Yanhua Li,1 Rui Chen,1, Hao Wang,1 Lin Wang,1 Mohan Liu,1
Minxin Guan2
1
Institute of Geriatric Cardiology of Chinese PLA General Hospital, Beijing
100853, China; 2Cincinnati Children's Hospital Medical Center, Division of
Human an Genetics, Cincinnati, OH 45229, USA

the blood pressure of maternal members was relevant with age, smoking, height
and high salt diet.
Conclusions: By far all findings, including the same mitochondrial DNA point
mutation in all maternal individuals and clear pattern of maternal inheritance,
suggested mitochondrial DNA point mutation may be associated with
hypertension and play an important role in onset of hypertension.

Objective: To find a novel mitochondrial DNA point mutation A4263G, we
characterized clinically and evaluated hereditarily a large Chinese family with
the characteristics of maternally inherited hypertension.
Methods: The mitochondrial DNA point mutation A4263G was detected by
sequence analysis of mitochondrial DNA from enrolled patients with essential
hypertension. Then we collected and did statistic analyses on the clinical data
of this family.
Results: All the members with mitochondrial DNA point mutation A4263G
were maternal members, a finding consistent with the maternal inherited
characteristics. The morbidity of hypertension in the maternal members is up
to 53.8%, while that in the nonmaternal members is only 11.8% (P<0.01); the
onset age of hypertension is tend to be advanced (from 64.3±5.0 y to 23.3±
2.9 y); the levels of blood glucose, total cholesterol and sodium of maternal
members were different with those of nonmaternal members (P<0.05), while
the results of echocardiogram has no difference between two groups. Finally,
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ANTIARRHYTHMIC EFFECT OF ATORVASTATIN ON
ISCHEMIA/REPERFUSION RATS
Hai-Chao Xu, Ling-Bo Qian, Xiao-Chen Ru, Hai-Feng Miu, Zhi-Guo Ye, Qiang
Xia
Department of Physiology, Zhejiang University School of Medicine / Mailbox
17, Zijingang Campus of Zhejiang University, 388 Yuhangtang Road,
Hangzhou 310058, China

to that Ator could prolong the ERP and increase VFT to enhance the cardiac
electrophysiological stability through NO pathway. However, the precise
mechanism of NO involving in the antiarrhythmic effect of Ator against
ischemia/reperfusion needs to be further explored.

Objective: To investigate the effect of Atorvastatin (Ator), a traditional bloodlipid lowering drugs, on arrhythmia induced by ischemia/reperfusion (I/R)
in SD rats and to explore its underlying mechanisms.
Methods: In isolated Langendorff-perfused rat hearts, arrhythmia was
produced by regional ischemia and reperfusion via ligation (for 30 min)
and release (for 15 min) of left anterior descending artery. The effect of
Ator on ventricular fibrillation threshold (VFT), effective refractory period
(ERP), and diastolic excitation threshold (DET) in rat heart were measured.
Results: We found that 10 µmol/L Ator significantly decreased the number
and duration of ventricular tachycardia (VT), delayed the occurrence of
ventricular premature beats (VPB) and VT induced by ischemia/reperfusion.
Ator also prolonged the ERP and increased the VFT (P<0.05, 0.01 vs. I/R
group) in the isolated perfused rat hearts during ischemia and reperfusion,
but did not affect the DET. However, L-NAME cancelled these
antiarrhythmic effects induced by Ator.
Discussion: The results suggest that Ator exerts its antiarrhythmic effects
against ischemia/reperfusion. This antiarrhythmic mechanism may be related

P31.
W-7, A CALMODULIN ANTAGONIST, DIRECTLY BLOCKS
HUMAN ETHER A-GO-GO RELATED GENE POTASSIUM
CHANNELS STABLY EXPRESSED IN HEK 293 CELLS
XH Zhang,1,2 MW Jin,1 GR Li2
Department of Pharmacology, Tongji Medical College of Huazhong
University of Science and Technology, Wuhan, China; 2Department of
Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong,
Hong Kong SAR, China

1

These results indicate that W-7 is a multiple-channel blocker by binding to
the closed channels of hERG, hKv1.5 and Kir 2.1. The concentrations of
ion channel blockage are lower than that of calmodulin inhibition; thus,
caution should be taken when it is used as a calmodulin inhibitor or a potential
anti-arrhythmic agent.

W-7 is a well-known calmodulin antagonist and believed to be a potential
anti-arrhythmic agent. The purpose of the present study was to determine
whether W-7 would block human ether a-go-go-related gene (hERG or
Kv11.1) potassium channel and human Kv1.5 and Kir2.1 channels.
Whole-cell patch voltage-clamp technique was used to record membrane
currents in HEK 293 cells expressing hERG, hKv1.5, or hKir2.1 gene.
We found that W-7 blocked hERG current (I hERG ) in a concentrationdependent manner (IC50: 3.5 µM). Blockade of hERG channels showed a
closed channel blocking property. Steady-state activation V 0.5 of hERG
channels was negatively shifted by 9.3 mV (from -5.1±1.3 mV of control
to -14.4±1.9 mV, n=11, P<0.01), while inactivation V0.5 was negatively
shifted by 9.9 mV (from -57.5±2.4 mV of control to -67.4±2.7 mV, n=7,
P<0.01) with application of 3 µM W-7. The S6 mutant Y652A, F656V
and the pore helix mutant S631A had a reduced channel block by W-7,
and IC 50 was 5.5 µM, 12.0 µM, and 24.6 µM, respectively. In addition,
W-7 inhibited human Kv1.5 channel (IC 50: 6.5 µM) and human Kir2.1
channel (IC50: 15.1 µM). The block also showed a closed channel blocking
property.
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EGFR KINASE REGULATES HUMAN CARDIAC NA(V)1.5
CURRENTS
YH Zhang, CP Lau, HF Tse, GR Li
Department of Medicine, Li Ka Shing Faculty of Medicine, The University of
Hong Kong, Hong Kong SAR, China
Nav1.5 is the pore-forming a-subunit protein of the cardiac sodium channels
which plays a pivotal role in the initiation and propagation of the cardiac
action potential. It is generally believed that cardiac sodium current (INa) is
regulated by protein phosphorylation. The present study was designed to
determine whether protein tyrosine kinases (PTKs) regulate human cardiac
Nav1.5 channels stably expressed in HEK 293 cells using a whole-cell patch
clamp technique.
It was found that human cardiac INa was enhanced by epidermal growth factor
(EGF, 100 ng/ml) or the protein tyrosine phosphatases (PTPs) inhibitor
orthovanadate (1 mM). The selective EGFR kinase inhibitor AG556 (5 µM)
remarkably inhibited INa amplitude, shifted the inactivation voltage toward
negative potentials, and slowed the recovery of INa from inactivation These
effects were countered by orthovanadate. However, insulin and the Src-family
tyrosine kinase inhibitor PP2 had no significant effect on INa.
These results suggest that EGFR kinase (but not Src-family kinase) and PTPs
regulate human cardiac Nav1.5 channels stably expressed in HEK-293 cells.
EGFR kinase positively, while PTPs negatively modulates the channels.
Additional experiments are required to confirm tyrosine phosphorylation level
of Nav1.5 using immunoprecipitation and Western blot analysis and to find
out the tyrosine phosphorylation site(s) of Nav1.5 using site-directed
mutagenesis.

P33.
CARDIOPROTECTIVE OF INTERMITTENT HYPOBARIC
HYPOXIA AGAINST ISCHEMIA/REPERFUSION INJURY IN
RAT HEART
Wei-Zhong Zhu, Jian-Wen Dong, Hai-Feng Zhu, Hai-Lei Ding, Xiu-Feng Wu,
Zhao-Nian Zhou
Physiological Laboratory of Hypoxia, Shanghai Institutes for Biological
Sciences, Chinese Academy of Sciences, Shanghai 200031, China
Abstract: The aim of this study was to investigate the mechanisms of
cardioprotection against ischemia/reperfusion-induced injury in rat hearts
adapted under intermittent hypobaric (IHH) hypoxia. Adult male SD rats were
put into the hypobaric chamber (simulated 5000m) for 6h daily, lasting 42
days. Isolated hearts were subjected to 30 min global ischemia followed by
30 or 120 min reperfusion. Glibenclamide, 5-hydroxydecunoate or pinacidil
were administrated before ischemia. Cardiomyocytes [Ca2+]i were measured
using a digital CCD. The activation and translocation of PKC-α, ε, and δ
isozymes, Bax and Bcl-2 were examined by Western Blotting; Incidence of
apoptosis in cardiomyocytes was determined by TUNEL.
Results: Post-ischemic functional recovery of LVDP and ±dp/dtmax were
better in IHH hearts. [Ca2+]i in cardiomyocytes from normoxic hearts
gradually increased during ischemia and kept at higher level during reperfusion.
However, in cardiomyocytes isolated from IHH hearts, [Ca2+]i kept at lower
level during ischemia and reperfusion. Glibenclamide and 5-hydroxydecunoate
respectively abolished this effect. However, they had no effects on nomoxic
myocytes. Pinacidil attenuated calcium overloading during ischemia and
reperfusion in normoxic myocytes, but had no effect on IHH myocytes. IHH
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up-regulated the baseline protein expression of particulate fraction of PKCα, ε, and δ. Ischemia and reperfusion induced the particulate/cytosolic ratios
of PKC-α, ε, in IH hearts was higher than those of normoxic hearts, and the
particulate/cytosolic ratio of PKC-δ, in IH hearts was higher than that of
normoxic hearts during ischemia period. Ischemia/reperfusion-induced
apoptosis was significantly reduced in IH group. After ischemia/reperfusion,
the expression of Bax in both cytosolic and membrane fractions were decreased,
and the expression of Bcl-2 in membrane fraction was upregulated in IHH
hearts.
Conclusions: The results indicated that KATP channels and PKC contributed
to the cardiaoprotection afforded by IHH against ischemia/reperfusion injury.
The elimination of calcium overload might underlie the mechanism of
cardioprotection. IHH attenuated ischemia/reperfusion-induced apoptosis via
increasing the ratio of Bcl-2/Bax in membrane fraction. (The study was
supported by grants: No.30393130; 2006CB504100)
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